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This dissertation considers an evaluation of the health education and patient navigation 
(PN) intervention, Friend to Friend plus Patient Navigation Program (FTF+PN).  In 2010, the 
Texas A & M AgriLife Extension Service was awarded outreach education funding by the 
Cancer Prevention Research Institute of Texas (CPRIT) to adapt the evidence-based program, 
Friend to Friend (FTF) in rural and border counties in Texas.  FTF consists of “pink parties” 
intended for an audience of lower income, un-/underinsured women aged 40+ who may be 
disabled, self-employed, and/or have limited English proficiency (LEP).  Increased funding in 
2012 supported the addition of four, fulltime equivalent patient navigators to join the team of 
four, full-time equivalent regional cancer prevention specialists to allow for follow-up and active 
support for women to obtain the screenings. 
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FTF+PN seeks to build an effective, sustainable infrastructure and overcome barriers to 
breast and cervical screening and diagnostic services to increase screening rates for underserved, 
un-/under-insured, and older women in approximately 60 rural and border counties.  The goal is 
to increase the number of women screened according to American Cancer Society (ACS) 
guidelines for breast and cervical cancer, thereby increasing the probability any cancers detected 
would be diagnosed in earlier stages.   At the time, ACS guidelines recommended annual 
mammograms for women aged 40-54 and biannual mammograms for those aged 55+ with 
average risk of breast cancer.  For cervical cancer screenings, recommendations included Pap 
tests every 3 years for women aged 21-29 and every 5 years for women aged 30-65 with no 
additional screenings needed for women aged 65+ if their previous results were normal.  
The goal of this evaluation is to demonstrate the efficacy of combining PN, a patient-
centered healthcare delivery model that utilizes trained lay navigators to integrate a fragmented 
system of care in order to reduce barriers to timely care for individuals and subsequently reduce 
disparities for population groups, with a health education intervention adapted for rural and 
border Texas.  Screening outcomes are also evaluated in light of county-level poverty rates and 
educational attainment to provide more comprehensive statistical models advancing scientific 
understanding of screening behavior among varying groups of women. 
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Chapter 1:  Introduction† 
Problem Statement 
Breast and cervical cancer are ranked as the first and fourth leading cancer diagnosis for 
women in the U.S. with late-stage diagnoses cited as a possible source of increased treatment 
difficulty and poorer outcomes for women whose cancer is not detected at an earlier, non-
metastatic stage.1,2  Given the prevalence of these cancers and variation in outcomes for different 
population sub-groups, public health policy and practice interventions have sought to identify 
un-/underserved women, including those living in rural areas, and connect them to resources to 
screen, diagnose, and treat breast and cervical cancers as early as possible.2 
Current literature indicate that rural women screen for breast and cervical cancer at lower 
rates than urban counterparts.3  Rural residents also suffer from later stage breast cancer 
diagnoses4 and higher breast and cervical cancer mortality rates5 compared to urban residents.  
These findings are further complicated by differences in race/ethnicity, scarcity of local 
healthcare services, a fragmented healthcare system, socioeconomic status (SES), and measures 
of area social deprivation that may factor into poorer outcomes for women in rural areas of the 
United States.5  Systematic literature reviews have assessed studies focusing on screening access 
and utilization,3 and stage of diagnosis4 for rural women, but none have reviewed interventions 
aiming to increase screening among rural residents. 
                                                 
†
A version of this chapter including its subsections was previously published following the dissertation defense.  
The committee reviewed and accepted this article for inclusion in the dissertation.  The material is reprinted with 
permission from Taylor and Francis Group. 
Falk, D. (2018). A mixed methods review of education and patient navigation interventions to increase breast and 
cervical cancer screening for rural women. Social Work in Public Health, 1-14. doi: 
10.1080/19371918.2018.1434583 
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SES status and rural residence also intersect with access to health insurance, which is 
often related to marital status.  Substantial literature documents the processes by which marital 
disruption leads to poorer health outcomes in light of reduced access to health insurance 
following a divorce.6-8  Furthermore, low-wage women also have a great deal of variability 
regarding access to health insurance depending on the composition of their employer, fellow 
employees, and marriage status due to the influence of these factors on the cost and subsidies 
provided through current health care legislation.9  While marital status is not assessed in this 
study, this factor adds still another dimension that generates disparate outcomes for rural women, 
especially in the face of economic restructuring and increased marital instability in rural areas.8  
As a result, interventions focused on providing access to health services for lower SES rural 
women bare even more relevance to this study. 
State specific legislation reducing publicly funded family planning services has also led 
to reduced access to care as these locations have served fewer women over time and limited their 
presence across the state.10,11  The loss of these providers, who often served larger roles in 
women’s health care by providing breast and cervical cancer screening, again impacts women of 
lower SES status and reduces the number of providers in areas already experiencing limited 
resources.  While the reduction in providers over time has not been assessed directly in this 
study, once again it justifies offering breast and cervical cancer screening services who can no 
longer rely on the few resources available for them, particularly in areas that demonstrate higher 
rates of cervical cancer in comparison to other parts of the state and the country.12 
Patient Navigation 
 Patient navigation (PN) emerged in the 1990s as a means to address breast cancer 
disparities by increasing screening among underserved women of color by reducing barriers to 
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care within a fragmented health care system.13  Since then, PN has drifted from its original 
clinical setting to include interventions across the cancer continuum with demonstrated efficacy 
in preventative screening uptake.14,15  However, its rapid adaptation across the country, including 
rural areas, has led to debate fostering greater formalization of what defines patient navigation in 
a professional context and how to measure its effect in health outcomes research.16,17  Even 
more, few studies (n=2) in rural settings have analyzed social work’s place in oncology PN as 
either navigators or serving in some other capacity within a PN intervention.18  In an attempt to 
integrate a diverse evidence base into practice standards, the Oncology Nursing Society, 
Association of Oncology Social Work, and the National Association of Social Workers issued a 
joint position stating a multidisciplinary team composed of a social worker, nurse, and lay 
navigator provide for optimal patient outcomes when using PN.19  This initial review seeks to 
identify and compare programs aimed at improving mammogram and Papanicolaou (Pap) 
screening rates for rural women who exhibit poorer screening behavior, later-stage diagnoses, 
and higher mortality rates than urban women. 
 Understanding PN and its functions have become even more critical as accreditation 
standards now require cancer treatment facilities to offer these services, which are defined by the 
Commission on Cancer as20: 
 “… specialized assistance for the community, patients, families, and caregivers 
to assist in overcoming barriers to receiving care and facilitating timely access to clinical 
services and resources.  Navigation processes encompass pre-diagnosis through all 
phases of the cancer experience.” 
However, other authors have noted navigation training and implementation depend greatly on the 
individual cancer program employing these services.21  Furthermore, the accreditation standards 
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clearly situate PN within an institutional setting despite the need for cancer care services in rural 
areas lacking facilities to meet these goals.  Consequently, PN has been defined more so by the 
goals of the intervention rather than a consensus of roles and duties for navigators across 
implementation sites.  An assessment of breast cancer PN programs used nine key principles 
rather than a taxonomy of duties to evaluate PN.22  These principles based on Freeman’s work 
included eliminating barriers to timely care, providing patient-centered care, integrating a 
fragmented system, navigating across a disconnected system, program cost, the navigator’s skill 
level, predetermined start and endpoints of navigation, the scope of the role, and system 
coordination.  Again, this study found different expressions of PN based on how each program 
chose to interpret PN within the context of its institution with varying levels of adherence to 
these principles.   
A national survey of patient navigators and their roles found basic navigation (assessment 
of needs, identification of barriers, problem solving based on needs, explaining PN services) 
were common across programs and employed lay, trained individuals in addition to medical 
professionals to perform these functions; however, treatment support and clinical trials/peer 
support required specialized professionals including social workers and nurses to perform these 
duties.23  The authors note three prevailing models of PN where the first involves a community 
member who negotiates with providers and is often a lay individual, the second involves 
screening and treatment navigation by social workers or nurses often in a clinical setting, and the 
third includes a multidisciplinary team of lay and professional navigators within a system of 
care. 
 Defining PN is further complicated by other programs that use community health workers 
to perform similar, but not necessarily the same, roles as navigators.24  This review found 
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practice location and population focus to be key determinates of how these functions were 
defined.  PN most often described clinic/hospital-based services, while community-based 
programs included community health workers, navigators, and/or advisors.  Even more, 
community-based programs tended to focus on specific racial/ethnic or rural groups in contrast 
to PN programs that focused on urban, low income and mixed racial/ethnic participants despite 
sharing goals of reducing barriers to care and improving outcomes for un-/underserved 
populations.  These differences were noted in another review of navigation in federally qualified 
health centers where community health workers focused on community-based interventions and 
included other titles such as lay health advisor, promotora, case manager, community outreach 
specialist, lay health educator, and lay health worker.25  Once more, PN was situated in clinical 
settings, although the study grouped these roles to assess their impact on service care delivery. 
Cancer Education 
 Cancer education is a specialized area of research and practice that is a key component to 
patient-centered care involving the participation of not only the patient and provider, but a much 
larger network of the cancer care team and patients’ friends and families.26  Critical components 
of cancer education consist of stakeholders, content, organization, and challenges.  Stakeholders 
range from basic scientists to personnel that interact with cancer patients and their providers.  It 
relies on the needs of the patients and their families in conjunction with the expertise of cancer 
care teams, rather than a paternalistic approach of experts determining what patients and their 
support system need to know.27  Content consists of specialized knowledge and training for 
purveyors of this resource.26  While much of this expertise resides in cancer care teams, interests 
in diversifying educational opportunities to broader audiences calls for the incorporation of 
cancer prevention and screening education beginning in school settings to instill cancer 
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education a lifelong learning opportunity.28  In addition, opportunities must exist outside of 
traditional institutions to incorporate communities in need of cancer education leveraging experts 
and trainees to reach underserved communities.29 
 Within organizations, cancer education should be adapted to the institution, incorporate 
best practices, coordinated among providers, and able to be evaluated in a systematic manner.26  
Thus, it requires a great deal of time and effort to achieve optimal results.  However, these efforts 
are limited by challenges, the last component of patient-centered cancer education.  First, 
funding models need to be developed to ensure adequate implementation.  Accessibility also 
poses challenges, and finally the field is in need of greater dissemination of best practices.  
Rurality 
 This project considers counties as rural, frontier, or border based on U.S. Census 
definitions of metropolitan and non-metropolitan areas that correspond to rural and urban 
categories.30  In addition, border and non-border designations are based on the La Paz Agreement 
of 1983 between the U.S. and Mexico defining counties that are within 100 kilometers of the 
U.S./Mexico border as “border counties”.30  Consequently, these definitions form the basis of the 
designations of rurality and rural residents used in this study. 
 Still, the concept of “rural” remains in debate by various governmental agencies and 
researchers.31-33  The variation of definitions based on population concentration, proximity to 
metropolitan areas results in complex resource allocations for social services that create 
methodological concerns for evaluation and practice.33,34 
 Given these differences, cancer outcomes for rural and urban comparison are difficult to 
measure.35  Some evidence points to variation in cancer incidence between rural and urban 
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residents; however, the evidence suggests that cancer-related outcomes are best understood by 
defining rural as the distance between residents and health providers and variation of screening, 
which appears higher for urban residents as they are in closer proximity to providers.35  Other 
evidence supports rural disadvantage with cervical cancer incidence ranging from 6% to 15% 
higher for rural residents compared to urban counterparts.35  Similarly, invasive breast cancer 
incidence has decreased by approximately 14% among women in urban areas while only about 
8% for rural women.35  These findings implicate screening as a major component contributing to 
this variation highlighting other literature that shows lower breast and cervical cancer screening 
for rural women that is even lower for women of color in comparison to non-Hispanic 
whites.36,37 
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Literature Review 
Systematic reviews of health literacy38 and patient navigation39 interventions to promote 
breast and cervical cancer screening highlight programs around the country that increased 
screening uptake using evidence-based interventions, yet the majority of these programs focus on 
urban settings with little consideration of environmental factors as a possible independent 
variable affecting screening outcomes.  Given the unique challenges that rural women may 
encounter when seeking breast and cervical cancer screening, a systematic review of quantitative 
research and a narrative review of qualitative research were conducted to identify studies that 
analyze education and patient navigation interventions to increase screening among rural 
populations.  This study seeks to identify and compare programs aimed at improving 
mammogram and Papanicolaou (Pap) screening rates considering the negative findings regarding 
poor screening, late-stage diagnoses, and higher mortality rates for rural women.  
Methods 
 A mixed methods review was conducted to identify studies that analyze education and 
patient navigation interventions to increase screening among rural populations.  For the 
quantitative review, a comprehensive search of Pubmed, Medline, the Cochrane Library, 
PsycINFO, and Web of Science was conducted to identify applicable studies.  As initial searches 
specifying breast and/or cervical cancer prevention education and patient navigation 
interventions in rural areas yielded few results, the key terms rural, breast, and cervical were 
expanded using medical subject headings (MeSH).  Inclusion criteria consisted of U.S.-based, 
English-language articles published between January 1990 to December 2016 that examined an 
education and/or patient navigation intervention using a control or comparison group and 
measured changes in screening completion as the main outcome. 
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Meanwhile, the qualitative review included a search of six databases (PsycINFO, 
PubMed, Medline, CINAHL, EBSCO, and Healthsource) for publications ranging from January 
2000 to December 2016 using key terms including “rural, breast, cervical, cancer, prevention, 
screening, patient navigation, and qualitative.”  To reflect on social work literature specifically, 
other sources were selected from reviews of applicable journals including but not limited to, 
Qualitative Health Research, Psycho-oncology, the Journal of Psychosocial Oncology, Social 
Work in Health Care, Health and Social Work, Social Work in Public Health, Qualitative Social 
Work, and Research on Social Work Practice.  References lists of selected publications were also 
reviewed to identify additional relevant articles. 
Inclusion criteria for qualitative findings consisted of U.S.-based studies published in 
English employing a qualitative methodology to examine attitudes, behavior, or PN 
programming related to breast and cervical cancer screening among a sample of rural women.  
Exclusion criteria consisted of (1) studies that focused on program development or 
implementation, and (2) studies of rural women’s experiences following a cancer diagnosis. 
Theoretical Framework 
The Theory of Reasoned Action (TRA) provides the theoretical framework used to 
categorize the qualitative results and is often employed in health behavior research including 
breast cancer screening (see Fig. 1.1).40,41  TRA posits that a behavior is proceeded by an 
intention to perform a behavior in which an individual’s attitude and subjective norm are directly 
related to the outcome.41,42  Behavioral beliefs and evaluations of behavioral outcomes are 
components of attitude, while normative beliefs and motivation determine subjective norm.  
Together, internal processes that determine attitude coupled with environmental qualities 
influencing subjective norm provide a measure of the intention to perform a behavior.  TRA’s 
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focus on how attitudes and behavioral intentions predict behaviors aptly conceptualizes the focus 
of the studies included in this review. 
Results 
Quantitative Findings 
A total of 2,280 records were identified from database searches (See Fig. 1.2).  Titles and 
abstracts for each record were evaluated with 341 qualifying for full-text review and 1,939 
excluded based on the initial assessment.  A closer examination of 329 articles during the full-
text review were rejected for failing to meet eligibility criteria, resulting in 12 publications 
included in the final analysis.  Screening outcomes varied by test performed as five studies 
exclusively focus on breast cancer prevention, while the remaining studies are divided between 
cervical (n = 2) and multi-cancer (n = 5) prevention interventions.  The articles also vary by type 
of intervention as eight are exclusively health education interventions and four more studies 
include patient navigation. 
Randomized control trials. Table 1.1 compares the reviewed quantitative studies across 
eight dimensions.  The references are organized by study design.  The first four are randomized 
control trials with two separate publications disseminating findings from the same research 
study.43-46  An education program for Latinas aged 50+ measured significantly higher odds of 
mammogram and Pap screening for intervention participants compared to a control group.44  The 
study was conducted in one rural county in Arizona along the U.S.-Mexico border.  A 
community-wide intervention compared rural farmworker communities in eastern 
Washington.46  Some communities received breast, cervical, and colorectal cancer screening 
education from the individual to organizational level, while others acted as control 
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communities.  No significant differences were found between the groups as penetration of the 
intervention may not have matched the sample surveyed.   
Paskett et al.45 and Katz et al.43 reported separate findings from the same intervention for 
mammogram and Pap screening, respectively.  Both studies found significant increases in 
screening rates among intervention participants compared to control groups following a theory-
based, lay health advisor education program on mammography screening.  The study was limited 
by possible cross-contamination of participants. 
 Quasiexperimental studies. Four articles tested interventions to increase mammogram 
screening in three southern states using a breast health education and patient navigation 
interventions.47-50  Two publications analyzed the same intervention in northern Louisiana where 
health centers were separated into three test groups:  enhanced care, education alone, education 
with nurse support.47,48  Nurse support increased mammogram screening in both papers.  The 
authors report variation among the participants in each arm prior to the intervention risking 
possible outcome bias.  The next study analyzed rural counties in North Carolina to test a lay 
health advisor intervention that demonstrated significant increases in mammogram screening 
rates among intervention counties compared to control counties.49  The study measured many 
ways of exposing women to the screening message that were included in the analysis.  However, 
this method limited the study’s ability to measure the intervention effect.  Finally, Powell et al.50 
compared churches demonstrating increased mammogram screening among participants who 
received education plus navigation, though it was limited to one, rural county in Alabama with 
possible cross-contamination among participants. 
 Two screening education studies demonstrated increased mammogram and Pap screening 
rates for intervention participants compared to comparison groups.51,52  A county-level, church-
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based intervention in eastern Arkansas trained survivors as educators to promote mammogram 
screening showed significant increases in screening rates compared to usual care groups.51  
Intervention participants were more often church attendees compared to those not receiving the 
intervention, leading to possible selection bias.  An educational intervention using a lay health 
adviser found significant increases in mammogram and Pap screenings for intervention 
participants compared to participants not receiving the programming.52  Participant location was 
used in a random effects model to control for variation between the test and control communities. 
 The last two quasiexperimental, education interventions included in the review 
experienced null outcomes.53,54  A study analyzed mammogram screening outcomes in three 
eastern Michigan counties receiving a community-wide education intervention with a 
comparison county in a different part of the state.53  Pre- and posttest measures recorded 
screening rates that did not vary significantly between intervention and control counties.  A 
cervical cancer education program for Latina farmworkers in southeastern Georgia changed 
screening knowledge but did not affect screening uptake.54  This article represented the only 
small study (N = 90) reviewed, which may account for the null finding as larger samples could 
detect more subtle effects.54 
Qualitative Findings 
Initial searches of qualitative literature yielded 234 articles for detailed review based on 
their title.  A review of the abstracts narrowed the selection to 93, and full-text review of these 
articles resulted in a final sample of 18 publications selected for inclusion.  Studies were 
analyzed thematically using TRA constructs.  After assigning applicable constructs to each 
article, content analysis of the studies’ findings revealed emerging themes grouped under each 
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TRA domain.  Table 1.2 organizes the studies by first author and year with a description of the 
study purpose, the sample size, setting, main findings, and associated TRA constructs. 
Behavioral Beliefs 
 Medical mistrust.  The studies varied in how the women graded their confidence in the 
medical system.  Most often, it presented as mistrust directed at medical care impeding their 
screening behavior.55-57  However, trust in providers was also viewed as engendering positive 
attitudes towards screening,55 while others noted that interventions should aim to reduce medical 
mistrust, particularly among minority communities.58  A unique finding on medical mistrust 
came from Leach et al.59 who describe a sense of alienation from providers due to patients’ 
perceptions of feeling judged due to excessive weight or smoking habits. 
 Prior experiences.  While one researcher situated medical mistrust proceeding 
experiences with the health care system,57 others indicated that prior experiences determined 
women’s attitudes towards screening.  Kelly et al.60 found that worry associated with a direct 
cervical cancer experience that evoked negative attitudes towards screening.  Similarly, Purtzer 
et al.61 found that former immobilizing and isolating cancer experiences impeded screening 
behavior.  Meanwhile, several studies cited similar themes related to prior negative experiences 
with health care or cancer influencing decisions not to screen among varying samples of 
women.58,62-64 
 Lack of knowledge/awareness.  This construct manifested as lack of knowledge 
surrounding breast health and screening64-66 as well as lack of awareness of the risk associated 
with breast cancer.57,65  Specifically, Filippi et al.65 uncovered a complete lack of risk 
association, while Purtzer’s57 finding that women had a low perception of risk was more 
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nuanced.  Head et al.64 also extended lack of knowledge not only to screening as in the case of 
Filippi et al.65 and Hubbell,66 but also to the human papilloma virus (HPV) and vaccination for 
cervical cancer. 
 Fear.  Three publications noted fear of cancer-related death as a barrier to screening.67-69  
Tejeda et al.69 also described fear in terms of the perceived physical pain associated with 
mammograms.  Engelman et al.67 distinguished fear among Hispanic women in comparison to 
non-Hispanic women. 
Normative Beliefs 
 Culture.  As evident in Table 1.2, these studies sampled from a broad range of rural 
communities with distinct cultural backgrounds and identities.  Not surprisingly, culture emerged 
from different applications of its effect on normative beliefs.  Canales et al.55 examined the 
impact of American Indian identity on screening behavior.  Language differences and its 
negative impact on provider communication was also apparent in another review.70  Finally, two 
studies offered a more positive perspective that breast health educational materials58 and 
preventative health communication71 should be culturally tailored to the receptive population for 
maximum impact. 
 Community.  Interpersonal connections often associated positive intentions towards 
screening.  Three studies found similar results of these relationships facilitating screening.56,63,69  
Findings also suggested leveraging these interpersonal relationships in order to disseminate 
cancer screening knowledge.71  In contrast, two studies in Appalachian Kentucky found negative 
views of interpersonal relationships as they discouraged cancer screening.64,72 
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 Embarrassment.  Three studies uncovered feelings of shame as a barrier to 
screening.64,67,68  The first study associated embarrassment with Hispanic women due to cultural 
views on modesty, noting that some women would only allow female health care providers to 
perform breast exams.67  Another study cited feelings of vulnerability and exposure during a Pap 
test but did not mention provider-related associations.68  Finally, social stigma against women 
who use public and reproductive health services negatively impacted cervical cancer screening in 
another study.64 
Control beliefs 
 Resources/cost.  Access to care hindered by cost, lack of health insurance, and/or 
geographic location was the most salient theme cutting across most studies included in the 
review.  Overwhelmingly, cost was cited as a primary impediment to screening.55,57-
59,64,65,68,69,71,72  Costs were measured holistically in terms of the screening exam, follow-up care, 
ancillary testing and fees, and opportunity costs during screening and possible future treatment.  
Lack of transportation, scarcity of providers, and geographic isolation also factored into 
screening intentions.56,59,62-64,66,70  Finally, one source specified access in terms of excessive time 
to screening and a fragmented system of care.70 
 Provider Communication.  Two findings illustrated how provider communication 
moved the locus of control away from the individual towards the professional.63,67  In the first, 
women were concerned about how providers communicated during the procedure and reporting 
the results following the exam.67  Meanwhile, another sample of women deemed provider 
communication as having both positive or negative effects on screening intentions and assessed 
their quality of care based on provider interaction.63 
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Limitations 
The lack of eligible studies limited the type and scale of analysis performed on the 
available data.  Variation among the sample limited conclusions regarding the effect of the 
interventions as pooling data to calculate an aggregate statistic on the effect of these 
interventions was inappropriate.  While not assessed quantitatively, publication bias also 
threatens the validity of the review’s outcomes as articles with negative or null findings are often 
not published.  The studies with null results for screening outcomes included in this review found 
some significant evidence of difference among comparison groups though they did not 
significantly improve screening rates. 
The inclusion of PN and rural among the search terms narrowed the available qualitative 
scholarship.  By doing so, it reveals a gap in the literature on the topic that currently receives 
more attention from other disciplines.  Yet the findings from the reviewed studies identify 
psychosocial barriers addressed most often by clinical professions often not trained in behavioral 
practice.  Moreover, the taxonomy of PN and limiting the scope to rural areas may simply 
underestimate social work’s contribution to the literature. 
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Table 1.1 
Education and/or patient navigation intervention studies to increase breast and cervical cancer screening among rural women 
from 1990 to 2016 (n=12) 
First Author Study design & 
setting 
Sample 
size 
Screening 
outcome 
Outcomes 
(+, -, 0) 
Intervention Behavioral 
Theory 
Cancer 
type 
Nuño44 RCT, 
Yuma Co., AZ 
381 Mammogram 
and Pap 
+ Education SCT Breast, 
cervical 
Thompson46 RCT,  
eastern WA 
2,083 Mammogram 
and Pap 
0 Education None Breast, 
cervical 
Paskett45 RCT, 
Robeson Co., NC 
851 Mammogram + Education SCT, TTM Breast 
Katz43 RCT, 
Robeson Co., NC 
775 Pap + Education SCT, TTM Cervical 
Davis47 Quasiexperimental,          
northern LA 
744 Mammogram + Education, 
PN 
SCT, HBM Breast, 
colorectal 
Davis48 Quasiexperimental, 
northern LA 
1,181 Mammogram + Education, 
PN 
SCT, HBM Breast 
Earp49 Quasiexperimental, 
eastern NC 
801 Mammogram + Education, 
PN 
SEM Breast 
Powell50 Quasiexperimental, 
Greene Co., AL 
197 Mammogram + Education, 
PN 
None Breast 
Erwin51 Quasiexperimental, 
eastern AR 
410 Mammogram + Education Locus of 
Control, TTM 
Breast 
Fernandez52 Quasiexperimental,         
TX-Mexico Border 
& CA Central 
Valley 
707 Mammogram 
and Pap 
+ Education None Breast, 
cervical 
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Table 1.1, cont. 
Gardiner53 Quasiexperimental, 
eastern MI 
1,545 Mammogram 0 Education None Breast, 
skin 
Luque54 Quasiexperimental,               
southeastern GA 
90 Pap 0 Education None Cervical 
Note: HBM-health belief model, PN-patient navigation, SCT-social cognitive theory, SEM-socio-ecological model, TTM-
transtheoretical model 
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Table 1.2 
Qualitative studies of breast and cervical cancer screening for rural women from January 2000 to October 2016 (n = 18) 
First Author Purpose of Study Sample size 
& Setting 
Main findings TRA constructs 
Canales55 Explicate factors 
influencing 
mammography 
decision making 
20 
Rural and urban 
VT 
Factors included native identity, self-
care, health care finances, and 
medical mistrust 
Beliefs, norms, 
control 
Daley58 Understand barriers 
to mammography for 
American Indian 
women 
66 
Rural KS and MO 
Barriers included Prior negative 
experiences with health care, need for 
culturally adapted educational 
material, interventions to improve 
medical mistrust 
Beliefs, norms 
Ely72* Identify barriers to 
follow-up cervical 
cancer care 
519 
Appalachian KY 
Individual, systemic, and community 
barriers were identified 
Beliefs, norms, 
control 
Engelman67 Analyze differences 
in mammography 
experiences between 
Hispanic and non-
Hispanic women 
88 
Rural and urban 
KS 
Hispanic women noted 
embarrassment and fear, while non-
Hispanic women were concerned 
with provider communication 
Beliefs, norms, 
control 
Erwin62 Understand 
opportunities and 
barriers for cancer 
screening among 
Latinas 
112 
Urban NY, rural 
and urban AR 
Country of origin and geographic 
residence determined perspectives on 
community-based religious 
organizations, experiences with the 
healthcare system, and access to 
services 
Beliefs, control 
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Table 1.2, cont. 
Filippi65 Examine perceptions 
of breast cancer 
screening among 
young American 
Indian women 
48 
Rural and urban 
KS 
The sample were unaware of risks, 
lacked screening knowledge, and 
worried about the cost of screening 
Beliefs, control 
Head64 Understand young 
women’s 
perspectives on 
cervical cancer 
prevention 
19 
Appalachian KY 
Barriers included beliefs about 
prevention, lack of knowledge, 
normative influences, and geographic 
isolation 
Beliefs, norms, 
control 
Hubbell66 Determine breast 
cancer screening 
factors among 
Mexican American 
women 
48 
Rural NM 
Barriers included lack of 
transportation, health care access, and 
screening knowledge 
Beliefs, control 
Kelly60 Understand the role 
of worry in cervical 
cancer screening 
24 
Appalachian OH 
Direct experiences with cervical 
cancer engendered negative feelings 
towards screening 
Beliefs 
Leach59 Identify barriers to 
cervical cancer 
screening among 
middle-aged and 
older women 
25 
Appalachian KY 
and WV 
Barriers included financial concerns, 
lack of resources, and alienation from 
health care providers 
Beliefs, control 
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Table 1.2, cont. 
Lyttle68 Understand attitudes 
about breast and 
cervical cancer 
screening 
69 
Appalachian WV 
Primary barriers included cost, fear, 
and embarrassment 
Beliefs, norms, 
control 
McMillan56 Understand rural 
working women’s 
perceptions of breast 
health 
42 
Appalachian TN 
Barriers included medical mistrust 
and access to care, positive 
interpersonal connections facilitated 
healthy behavior 
Beliefs, norms, 
control 
Pinzon-Perez70 Identify determinants 
of Pap screening for 
Latinas 
51 
Rural Central 
Valley CA 
Barriers included excessive time to 
screening, fragmented system of care, 
and language differences  
Norms, control 
Purtzer57 Discover the process 
of rarely or never-
screened women’s 
mammogram 
decisions 
17 
Rural WY 
Factors influencing screening 
decisions included social isolation, 
medical mistrust, and perception of 
low risk 
Beliefs, control 
Purtzer61* Investigate catalysts 
of mammography 
screening 
25 
Rural WY 
Immobilizing and isolating cancer 
experiences impeded screening, while 
motivation and self-efficacy were 
associated with screening 
Beliefs 
Sentell71 Investigate health 
communication 
challenges among 
Native Hawaiians and 
Filipinos 
77 
Rural HI 
Suggested improvements included 
leveraging the role of interpersonal 
relationships in dissemination of 
cancer information and local, 
culturally tailored communication 
Norms 
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Table 1.2, cont. 
Tejeda69 Explore barriers and 
facilitators of 
mammogram 
screening among 
lower educated 
Mexican women 
40 
Rural WA 
Barriers included lack of insurance, 
perceived physical pain, and fear; 
positive interpersonal relationships 
facilitated screening 
Beliefs, norms, 
control 
Torres63 Understand factors 
associated with breast 
or cervical cancer 
screening among 
Latinas 
45 
Urban NY, rural 
and urban AR 
Prior health care involvement, access 
to resources, and communication 
impacted screening both positively 
and negatively; positive interpersonal 
relationships facilitated screening 
Beliefs, norms, 
control 
Note:  TRA=Theory of Reasoned Action, *=Included at least one MSW-level author 
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Fig. 1.1. Constructs of the Theory of Reasoned Action. 
BehaviorBehavioral intention
-Behavioral beliefs
-Attitude toward 
behavior
-Normative beliefs
-Subjective norms
-Control beliefs
-Perceived behavioral 
control
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Fig. 1.2. Flowchart of quantitative study identification. 
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Chapter 2:  Gaps in Research 
Quantitative Gaps 
With only 12 articles and 10 interventions over a 26-year period, the paucity of 
quantitative literature on breast and cervical cancer prevention interventions in rural areas using 
health education and/or patient navigation suggests a need for adaptation, implementation, and 
evaluation of evidence-based interventions in these areas.  The study originally intended to 
compare the studies’ effect sizes in a meta-analysis; however, the variation in design, 
interventions, and outcomes among the sample precluded a quantitative analysis.  The sampled 
studies ranged in setting from Washington to Georgia, but most were in Southern states (n=9) 
compared with the few studies taking place in Western (n=2) or Midwestern (n=1) states and 
omitted many rural areas of the country completely.  Only four articles and three interventions 
included patient navigation, which varied distinctly in implementation across the studies though 
all reported successful screening improvements.  Similarly, education interventions ranged from 
a mailed pamphlet to individual, lay health advisor-led sessions at participants’ 
homes.  Consequently, outcomes from meta-analyses would provide little interpretive value due 
to the wide range of intervention approaches. 
Still, the publications offer insight into tested programs for specific rural populations 
around the U.S.  In that sense, the adaptation to community characteristics favors diverse 
interventions accommodating local variation.  Most of the articles benefit from large sample 
sizes despite their rural setting.  Also, all but five of the articles mentioned at least one 
behavioral theory as part of the conceptual framework of the intervention, yet the studies 
inconsistently related theoretical constructs to measurement tools.  Of the articles failing to 
 26 
 
mention a theory, three reported null findings while all studies including a theory reported 
screening improvements in intervention over control groups. 
Finally, both health education and patient navigation interventions need greater 
theoretical refinement.  The publications included in this study cited three behavioral theories for 
their conceptual frameworks.  Nuño et al.44 used social cognitive theory (SCT) exclusively, while 
Davis et al.47,48 combined SCT with the health belief model (HBM) to inform their intervention.  
The conceptual framework for the Robeson County Outreach Screening and Education Project 
employed SCT and transtheoretical (TTM) constructs,43,45 and the Witness Project used TTM 
and locus of control.51  A detailed conceptual framework allows for more critical evaluation of 
the studies’ findings while connecting interventions to an established knowledge base.  Analysis 
health education together with PN necessitates a theoretical framework that employs both SCT 
constructs rooted in observational learning with stages of changes garnered from TTM. 
Additionally, rural areas need greater implementation and evaluation of screening 
interventions using health education and patient navigation as these services address the 
challenges of delivering high quality cancer care to populations in un-/underserved 
communities.  The relative dearth of intervention studies on breast and cervical cancer education 
and patient navigation programs compared to urban studies highlights the need for validation of 
urban programs among diverse, rural populations. 
Qualitative Gaps 
Qualitative findings reveal intra- and interpersonal barriers to cancer care for rural 
women that require psychosocial support beyond traditional clinical services to truly provide 
person-centered cancer care.  While patient navigation maintains a wide range of professional 
and non-professional roles, this study situates the knowledge, skills, and abilities developed in 
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social work education at the center of interventions that address comprehensive psychosocial 
needs for rural women beginning with screening.  Still, this assessment faces practical challenges 
as qualified professionals capable of navigating these psychosocial barriers are scarcely available 
in rural areas.  Health disparities will persist while systems of care remain static; however, 
transdisciplinary practice and technological advances may offer some solutions for social work 
education, practice, and research. 
TRA offers a framework to understand the cognitive processes of rural women deciding 
(or not) to screen for breast and cervical cancer.  These women provide insight into the 
decisional balance that precedes psychosocial needs post-diagnosis.  Evidence from this 
synthesis points to psychosocial barriers that influence screening behavior underscoring the need 
for interventions that identify women at a pivotal stage to educate and connect them to services.  
To impact behavioral beliefs, interventions must address mistrust in the healthcare system often 
resulting from prior negative experiences.  Also, they need education about their risk of these 
cancers and the benefits of screening.  Regarding normative beliefs, community support 
consisting of direct interpersonal relationships can positively influence screening behavior 
intentions, and interventions must consider cultural variation in their design to have the greatest 
impact especially among racial and ethnic minority women.  Finally, rural women are 
particularly concerned about the costs of screening and resources available to screen and receive 
continued care if they were diagnosed with cancer.  At times, women simply are unaware of the 
assistance programs available to them; however, they also measure costs broadly including the 
opportunity costs if cancer was detected during screening and weigh these against the benefits of 
early detection.  Thus, a comprehensive approach to encouraging these women to screen include 
care plans that mitigate these concerns. 
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Chapter 3:  Implications for Social Work 
Implications for Education 
Multidisciplinary education feeds innovative practice methods to real-world settings as 
health care responds to complex issues in population health.73-75  The need for new educational 
paradigms have led to the development of online programs76 with the potential to train students 
interested in pursuing social work in remote locations.  In addition, dual degree programs in 
social work and public health77 leverage overlapping areas of practice and research leading to 
innovative career paths for graduates.78,79  Finally, leadership in oncology social work have 
responded with continuing education initiatives for practitioners addressing areas including 
multidisciplinary collaboration while maintaining social work values of person-centered, 
culturally-sensitive, and evidence-informed practice.80  Professional development opportunities 
include certification as an oncology social worker trained in clinical settings.81  Partnerships with 
other cancer care organizations such as the American Cancer Society, CancerCare, and the Lance 
Armstrong foundation broadens the impact of oncology social work to offer psychosocial 
services for all cancer patients.81 
The experience and research of social work education has developed professional 
standards that guide human service functions from a theoretical and scientific basis that 
incorporate a multidisciplinary foundation in order to address a range of socioecological factors 
that contribute to an individual’s health and wellbeing.82  Therefore, while outcomes research 
play an integral role in evaluating interventions, the complexities of human behavior are often 
reduced to compliance without deeper understanding of the psychosocial processes not only of 
those who “succeeded” in performing the desired behavior, but also those who fail to act as the 
intervention intends.  Social work education and practice speak to the psychosocial needs of both 
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groups.  Psychosocial oncology practice is best embodied by professional organizations such as 
the Association of Oncology Social Workers and the American Psychosocial Oncology Society 
that envisions high quality standards of care for cancer patients, families, and caregivers that 
address the range of their psychosocial needs.81,83  Their efforts specialize the field of 
psychosocial oncology with continuing education and certification denoting the unique 
qualifications that trained practitioners have developed to meet the needs of the patients and 
extended networks.  Therefore, these individuals already model whole-person cancer care. 
Implications for Practice and Research 
Cancer-related disparities and population health outcomes have led to new leadership 
roles in accountable care organizations for social workers to leverage their experience to respond 
to this change.84  Clinical settings such as those mentioned offer ideal locations to connect the 
community to the health care system.  However, rurality again challenges this interface as 
hospitals with resources capable of prioritizing these activities often serve large regions.   
Reaching rural women in need requires leveraging resources to bridge service gaps.  Jang 
et al.85 described isolation in terms of a linguistic community within an urban area and 
demonstrated positive behavioral outcomes using telecounseling services provided by social 
workers.  This study connected highly specialized social workers with the required language 
skills to service clients at great distances.  One limitation to this approach is rural access in areas 
where markets may not be conducive to major technological investment, thus creating a “digital 
divide” in comparison to urban areas.86  As technology advances with greater smartphone use 
and continued research into telehealth and mental health services, incorporating these advances 
show promise for interventions involving geographically isolated individuals.87-89 
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Refinement of PN requires documenting roles and functions of current programs90,91 in a 
similar way that social work has developed a taxonomy for clinical social workers in 
multidisciplinary teams in clinical settings.92  While we can define these roles within our own 
profession, we must work collaboratively with other disciplines to articulate the value of social 
work’s contribution to PN through continued practice and research.    
The potential for genomics and precision medicine in cancer have an unclear impact on 
health disparities considering socioecological factors that contribute to gene expression;93 
nevertheless, oncology social work must consider the ethical, legal, and psychosocial issues 
while providing genetically and ethically informed practice to underserved groups.94,95  
Formative research has identified psychosocial concerns of women with genetic predisposition 
for breast cancer96,97 shaping potential social work practice in genomics and broadening the 
definition of cancer prevention.   
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Chapter 4:  Policy Environment 
A range of national and state policies have created opportunities to improve cancer-
related health outcomes for un-/underserved women by promoting breast and cervical cancer 
preventative screening while fomenting collaboration among various healthcare-related 
disciplines.  However, policies have also presented more barriers to women’s health negatively 
impacting breast and cervical cancer screening capacity.  National legislation is presented in 
reverse chronological order to trace the development of policies, while state legislation is 
grouped thematically.  
National Policies 
The following legislation outlines the most influential policies affecting breast and 
cervical cancer prevention efforts at a national level.  The chronologic progression illustrates 
how policy refinements resulting from research demonstrating the effectiveness of prevention 
interventions.  Further, they represent the value of public investment in reducing the impact of 
these cancers for the population.  This review also denotes the years of investment from 
policymakers and researchers to develop an increasingly comprehensive approach to prevent and 
treat breast and cervical cancer. 
The Patient Protection and Affordable Care Act (ACA) of 2010. The ACA (2010) 
intended to expand healthcare access primarily through increased participation in health 
insurance among individuals formerly uninsured.  Healthcare plans were now also required to 
include preventative health services, including mammograms and Pap tests, at no cost to 
participants in order to reduce barriers to preventative screening.99  Insurance status has a high 
impact on preventative care utilization.  For example, only 43.3% of low-income women without 
insurance in Texas have had a mammogram in the past 2 years compared to 71.4% of low-
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income women with insurance based on data from the 2013 Behavioral Risk Factor Surveillance 
System (BRFSS).100  Similarly, 67.7% of low-income women without insurance in Texas have 
had a Pap test in the past three years compared to 80.8% of low-income women with 
insurance.100 
The ACA (2010) expanded access to low income individuals by giving states funds to 
expand Medicaid through broader enrollment.  Texas, however, opted not to participate in 
Medicaid expansion, resulting in a loss of approximately $9.2 billion by 2022 in federal funding 
earmarked for expansion of these services for the state due to lost federal funds.101  As a 
consequence, millions of Texans who cannot afford insurance and would qualify for Medicaid in 
other states remain without insurance.  This risks women’s health as this policy translates to 
687,000 Texan women (27.6% of uninsured Texan women) who are unable to access Medicaid 
as intended by the ACA.100   
The ACA (2010) improved healthcare access in other ways.  Provisions included 
continued coverage for young adults, who can remain on their parent’s health insurance policies 
until they are aged 26 years.  This benefit reaches young women when they are at the greatest 
risk of becoming infected with HPV.102  Vaccinations, including those targeting HPV, are 
included in health plans at no cost sharing for participants.  Access to these vaccines have the 
potential to greatly reduce the incidence of cervical cancer by targeting this known cancer-
causing agent, yet evidence shows only 32% of the targeted population have opted for 
inoculation.103 
Cost of care is a major concern for individuals and families and has been noted as a key 
barrier for cancer patients seeking treatment.104,105  Out-of-pocket expenses for care worried over 
a third of cancer patients, while 37.1% reported being concerned about bankruptcy due to cancer 
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treatment.106  The ACA (2010) prohibited healthcare plans from setting lifetime limits on 
coverage and eliminated preexisting conditions as a reason for denying enrollment.  Still, 
premiums, deductibles, and co-pays remain financial barriers to cancer treatment.  Evidence 
supports these concerns as one study found that cancer patients had a 2.65 times higher odds of 
declaring bankruptcy compared to than those without cancer.107 
Beyond insurance, the law outlined several priorities to improve population health.  First, 
the ACA (2010) called for improved coordination and quality of healthcare.  While these 
provisions are not specific to cancer care, they touch on issues common in the cancer care 
continuum.  This mandate underlines the challenges that cancer care providers may face such as 
disjointed services, complex treatments, and rising costs.108  The ACA (2010) also addressed 
health disparities.109  Medicaid expansion is cited as a primary means to reduce disparities as the 
impact directly affects people of color, who represent over half of the currently uninsured.110  
Also, it provided for increased data collection on race, ethnicity, primary language, disability 
status, and gender and extended civil rights nondiscrimination laws to healthcare providers 
receiving federal funding.  The law expanded the National Health Service Corps, which provides 
funding and placement of health professionals to areas where shortages exist.109  Community 
health workers, including patient navigators, are also funded to provide culturally and 
linguistically appropriate services to underserved areas. 
Patient Navigator Outreach and Chronic Disease Prevention Act of 2005.  The 
Patient Navigator Outreach and Chronic Disease Prevention Act of 2005 resulted from the work 
of oncologist Harold Freeman.13  Recognizing the barriers faced by African American (AA) 
women of low socioeconomic status (SES) in cancer treatment, Freeman developed a PN 
program to improve cancer-related outcomes.112  The program provided free screening and PN 
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services to medically underserved men and women living in Harlem.  Outreach and educational 
programming helped identify at-risk individuals and recruit them into care services.  By 
identifying and removing barriers for patients,113 screening rates improved and contributed to the 
development of policies culminating in this legislation.114 
The law authorized the establishment of the National Cancer Institute’s (NCI) Center to 
Reduce Health Disparities to fund demonstration projects using Freeman’s model.104  Since then, 
over 300 programs funded by NCI and the ACS were found to use this model to increase cancer 
screening among racial and ethnic minorities and low SES individuals.115,116  The ACA (2010) 
reauthorized funding for the act and cites PN explicitly as a means to reduce disparities for 
racial/ethnic groups, eliminate barriers to care, and integrate healthcare systems for improved 
outcomes.  While reducing disparities remains the ultimate goal of this and other initiatives, 
research thus far has focused primarily on identifying groups with disparate outcomes and testing 
interventions aimed at increasing screening and treatment for these groups.117   
 The Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA) of 2000.  
The BCCPTA (2000) functions in tandem with the Breast and Cervical Cancer Mortality 
Prevention Act (BCCMPA) as Breast and Cervical Cancer Services (BCCS) to provide treatment 
services to women diagnosed with breast and cervical cancer.  This legislation funds Medicaid 
expansion for women diagnosed with pre-cancer or cancer so that they can seek treatment 
without the concern of cost.  Each location (state, territory, or tribal area) determines the level of 
need required to access Medicaid via this program.119  However, all states had implemented this 
optional program by 2005 thereby paving the way for women of low SES to access breast and 
cervical cancer care.  While Medicaid enrollment lengthens the treatment initiation time to 
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approximately 2 weeks, the additional time is unlikely clinically significant and worth the 
tradeoff of covering cancer care expenses. 
 These complementary policies echo elements ACA (2010).  Full coverage of preventative 
services, expansion of healthcare coverage, and goals of reducing disparities while improving 
outcomes show evidence of continued development towards improving cancer care, especially 
for low SES, minority women.120  Despite this seeming overlap in coverage, the latter programs 
remain important to women’s health as the lack of Medicaid expansion under ACA in some 
states still puts low SES women at risk.  Even after implementation of the ACA (2010), the 
women served by BCCMPA and BCCPTA are estimated to increase.121  However, less than a 
third of women eligible for BCCMPA and BCCPTA access them.122  Eligibility criteria include 
residing in Texas, not having health insurance, aged 18+, and earning up to 200% of the Federal 
Poverty Level (FPL).123  These two findings point to the need for interventions that reach out to 
women needing these services to raise awareness of available options, to screen, and then to treat 
those diagnosed with cancer. 
 The Breast and Cervical Cancer Mortality Prevention Act (BCCMPA) of 1990.   
This law authorizes funds for the CDC’s National Breast and Cervical Cancer Early Detection 
Program (BCCEDP).  This program provides screening to un-/underserved elderly, low-income, 
and racial/ethnic minority women through a competitive grant review process.119  This law 
recognizes the unequal burden of cancer for women and disparities for racial and ethnic 
minorities compared to non-Hispanic white (NHW) women and aims to reduce morbidity and 
mortality for these cancers.125  The provisions of the act include funding of public health 
agencies, state and territorial health departments, and American Indian and Alaskan Native tribes 
to screen and diagnose women for breast and cervical cancer.119  Furthermore, the program 
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includes case management services, data collection, outreach, and education services.  As of 
1997, the program had achieved participation from all 50 states, the District of Columbia, five 
territories, and 11 tribes.  To qualify for Medicaid for Breast and Cervical Cancer (MBCC) in 
Texas, a woman must have a previous breast or cervical cancer diagnosis, need treatment, reside 
in the state, be a U.S. citizen or resident, be between 18-64 years of age, not have health 
insurance, and may earn up to 200% of the FPL.123 
 The BCCMPA provided for screening services with the expectation that local agencies 
would contribute towards treatment once women were diagnosed.119  However, the need to fund 
treatment was recognized in further legislation due to concerns that individuals diagnosed were 
not receiving or delaying treatment because of cost.  Thus, additional legislation made way for a 
more comprehensive approach to include un-/underserved women. 
 Population Research and Voluntary Family Planning Programs of 1970.  Commonly 
referred to as “Title X” of the Public Health Service Act, this statute designates funding for 
family planning and preventative health services including access to cervical cancer screening.  
Assessments of Title X funding have found many positive results.  Since its inception, cervical 
cancer has dramatically been reduced from the leading cause of cancer for women in the U.S. 40 
years ago to now the 14th most common cancer diagnosis.127  Pap tests are cited as the main 
reason for this change, and the lack of access to this preventative screening is considered the 
reason for disparate rates of cervical cancer incidence among population groups.127 
 Cervical cancer screening along with the other services provided by Title X result in 
tremendous savings for government programs.  In 2010, estimates reached $13.6 billion in 
government savings translating to a return on investment of $7.09 for every $1 of public 
investment.128  Clinical services account for the majority of spending under Title X at 90%.129  
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Over 1.5 million screenings occurred at Title X service sites in 2011 with approximately 15% 
detecting pre-cancerous or cancerous lesions requiring further evaluation.130   
 Title X funded service sites are also an essential resource for immigrant women as they 
are not required to verify their legal status.131  Furthermore, legal immigrants are barred from 
receiving Medicaid services for the first five years of residency, thus reducing their access to 
quality healthcare, while undocumented immigrants only receive Medicaid in emergency 
situations.  Title X clinics also must provide linguistically appropriate care thereby facilitating 
their needs even more. 
Despite the reduction of incidence of cervical cancer associated with the enactment of 
Title X programming,127 congressional appropriations have continued to reduce its funding with 
some calling for the elimination of provisions completely.132  Since its inception, Title X has 
received a maximum of $317 million in 2010 with levels declining since then despite the need 
for increased funding to adequately cover these services for women in need.132 
Texas Policies 
 Legislation in Texas follows similar patterns to national efforts regarding cancer control 
and prevention.  Seeking to reduce the impact of cancer for individuals and reducing the 
economic burden to the state,133 the first pieces of legislation discussed reference broad-based 
initiatives supporting cancer research and prevention efforts.  Cervical cancer prevention, 
however, has suffered from a series of policies limiting resources due to its association with 
abortion and family planning services.  These policies are outlined in the latter part of this 
section with a discussion regarding cervical cancer screening and access to women’s health 
services. 
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 Art. III, Sec. 67 of the Texas Constitution.  In 2007, a constitutional amendment 
established the Cancer Prevention Research Institute of Texas (CPRIT)134 as a funding 
mechanism to support innovative cancer research, including evidence-based interventions, 
through investment in higher education institutions and other public and private entities.  Bonds 
totaling $3 billion were issued to fund research and services with a goal of reducing the impact 
of cancer in the state while fostering innovative research by Texas-based researchers. 
 Beginning in 2009 and expiring in 2021, the grants fund basic science research, 
prevention interventions, commercialization of related drugs and devices, and other related 
services.134  In 2014, over $292 million were awarded through 169 grants with over 420,000 
Texans benefitting from prevention and control services.135  Of the active prevention grants in 
2014, 34 grants addressed breast cancer while 26 included cervical cancer.  Preventative 
screening and diagnostic exams was provided to over 433,000 Texans for breast, cervical, and 
colorectal cancer, and over 956,000 received education and training interventions.  Texas’ 
investment in cancer research is considered the largest source of non-federal public cancer 
funding in the U.S.  Basic science research grants represented the largest share of funding 
expenditures at 54%, followed by funding for cancer treatment at 25%, and prevention 
interventions at 11%.  The rest of the grant distribution included cancer etiology (6%), scientific 
model systems (2%), and cancer control, survivorship, and outcomes (2%). As of 2014, more 
than $504 million has been awarded to fund scientific research in cancer biology, treatment, and 
prevention. 
 CPRIT grant funding was suspended for a 10-month period due to questionable allocation 
of funding.136,137  Despite recommendations from scientific review, several grant applications 
were denied in lieu of ones with commercial merit.137  The controversy led to a criminal 
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investigation and the resignation of Alfred Gilman, Nobel laureate and former chief scientific 
officer of the agency.137  In 2013, grant funding was continued after oversight changes.138 
 S.B. No. 53.  The Legislative Task Force on Cancer in Texas established the Texas 
Cancer Council in 1985 through strategic legislation aimed at reducing the burden of cancer in 
the state through coordination of public, private, and volunteer efforts.139  The primary method of 
carrying out this mission is by means of the Texas Cancer Plan, focusing on prevention planning 
by promoting intervention programming that increases access, availability, and quality of 
resources for screening and diagnostic services.140  This legislation was a precursor to the 
establishment of CPRIT, which has since been mandated with the continuation of the Texas 
Cancer Plan and funding prevention and other cancer-related research previously described. 
 S.B. No. 1051. Mirroring the passage of the federal Patient Navigator Outreach and 
Chronic Disease Prevention Act of 2005, the Texas legislature formalized the rules for 
community health workers in 2015 with S.B. No. 1051.141  S.B. No. 1051 defines community 
health workers as: 
A person who, with or without compensation is a liaison and provides cultural mediation 
between health care and social services, and the community. A promotor(a) or 
community health worker: is a trusted member, and has a close understanding of, the 
ethnicity, language, socioeconomic status, and life experiences of the community served. 
A promotor(a) or community health worker assists people to gain access to needed 
services and builds individual, community, and system capacity by increasing health 
knowledge and self-sufficiency through a range of activities such as outreach, patient 
navigation and follow-up, community health education and information, informal 
counseling, social support, advocacy, and participation in clinical research.141 
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 H.B. No. 2.  House Bill No. 2 (2013) enacted several restrictions on abortion services in 
Texas.143  The law requires doctors performing abortions to have admitting privileges at hospitals 
within 30 miles of the clinic, bans abortions after 20 weeks, requires women to attend two 
separate doctor’s visits prior to receiving abortion-inducing drugs and one visit 14 days 
following the appointment.  In addition, later amendments require abortion facilities to be 
ambulatory surgical centers.  The added regulation of these services has caused a steady decline 
of qualifying clinics from 25 as of March 2014 to 18 as of June 2015 with only eight of these 
locations operating as ambulatory surgical centers.144  A U.S. Supreme Court case found these 
laws to be unconstitutional as they do not improve women’s safety but result in greater 
restrictions for women seeking abortions.145   
 S. B. No. 747.  Passed in 2015, this law makes it illegal for facilities providing family 
planning services to receive Medicaid funding.   It targets Planned Parenthood because they 
provide abortions to women, thus forcing them to close and limiting access to other sexual health 
services, such as Pap screening, particularly for low-income women who rely on Medicaid. 
 S.B. No. 7.  This previous law enacted in 2012 stops the use of taxpayer funds for 
abortion services.  Together with the previous mentioned legislation, they represent a concerted 
effort to restrict abortions for women in Texas.  By attacking Planned Parenthood, however, it 
weakens cancer prevention efforts by eliminating another provider of Pap tests and other sexual 
health services for un-/underserved women. 
 Legislation in process.  Texas continues to impose limitations on abortion access 
intended to harm women’s health organizations.  Senate Bill 8 includes a ban on fetal tissue 
donation, requires fetal tissue to be buried or cremated, bans a common abortion procedure, and 
bans private insurance coverage for elective abortions.146  The fetal tissue burial or cremation 
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requirement has already faced legal challenges with a U.S. district judge ruling the requirement 
unconstitutional.  Also, Senate Bill 4 prevents government entities from partnering with abortion 
providers and their affiliates.146   
Policy Implications 
Resources such as Planned Parenthood and other organizations serve a vital role in 
healthcare for underserved populations, yet political views on women’s health have impacted 
their health and safety.  H.B. No. 2 and similar laws are touted as an effort to protect women’s 
health through higher standards for facilities providing abortion; however, eliminating one of the 
few community partners serving women’s health imperils their access to cervical cancer 
screening and other sexual health services, including human immunodeficiency virus (HIV) 
screening.  Limiting providers has decreased mammogram and Pap screening by 14 to 23 percent 
among Latinas in Texas while no significant change was found for NHW women.147  Lower 
educated women also screened at lower rates under these new policies.148  Other studies have 
found a decrease in contraception coupled with an increase in childbirth rates covered by 
Medicaid.149 
 For social workers and allied professions, these policies do not frame a cohesive 
approach towards increasing screening among un-/underserved women as some policies conflict 
directly with the aims of others.  However, they provide some tools to advance health equity.  
The policy gaps also highlight areas where research and practice offer solutions to improve 
community health.  To help shape supportive policies, legislators and the public must be 
educated about the benefits to greater health care access.  
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Chapter 5:  Overview of the Three Papers‡ 
Paper 1:  Increasing Breast and Cervical Cancer Screening in Rural and Border Texas 
with Friend to Friend plus Patient Navigation 
Introduction 
Racial/ethnic minority and rural women experience lower screening rates and delays in 
mammograms and Papanicolaou (Pap) tests compared to non-Hispanic white (NHW) women 
and urban residents leading to a greater cancer burden for these individuals.36,37  Diagnostic and 
therapeutic delays may lead to greater treatment difficulty and increased cost for both the 
individual and healthcare system as breast is the leading and cervical is the fourth leading cancer 
diagnosis among women nationally and in Texas.1  Early detection of breast and cervical cancer 
through screening may improve survival and decrease mortality rates by detecting malignancies 
at a non-invasive stage, resulting in more successful treatment.2  As a result, improving the 
wellbeing of underserved communities by reducing the impact of these cancers for minority and 
rural women remains a priority for policy makers, researchers, and clinicians.150 
Researchers have developed interventions aimed at improving screening rates for 
racial/ethnic minority and rural women through health education and patient navigation 
(PN).151,152  PN, an evidence-based practice within the cancer care continuum and other diseases, 
is a patient-centered healthcare delivery model that utilizes trained lay navigators to integrate a 
                                                 
‡A version of the first paper in this chapter was previously published prior to the dissertation defense.  The 
committee reviewed and accepted this article for inclusion in the dissertation.  The dissertator contributed to the 
design, performance, analysis, and writing of the article.  The other authors reviewed and supplied technical 
expertise.  The dissertation committee determined the contribution by the dissertator and content were acceptable for 
inclusion in the dissertation. The material is reprinted with permission from the American Association for Cancer 
Education, Springer. 
Falk, D., Cubbin, C., Jones, B., Carrillo-Kappus, K., Crocker, A., & Rice, C. (2016). Increasing breast and cervical 
cancer screening in rural and border Texas with Friend to Friend plus Patient Navigation. Journal of 
Cancer Education, 1-8. doi: 10.1007/s13187-016-1147-6 
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fragmented system of care in order to reduce barriers to timely care for individuals and 
subsequently reduce disparities for population groups.104 
The objective of this paper is to evaluate programmatic outcomes of a health education 
and PN intervention for rural women in Texas by identifying sociodemographic and other 
screening-related factors that (1) distinguish participants who chose PN services from those who 
did not (non-PN); and (2) were associated with receiving a mammogram or Pap test. 
Intervention 
 In 2010, the Texas A & M AgriLife Extension Service was awarded outreach education 
funding by the Cancer Prevention Research Institute of Texas (CPRIT) to adapt the evidence-
based program, Friend to Friend (FTF) in rural and border counties in Texas.153  FTF consists of 
“pink parties” targeting an audience of lower income, un-/underinsured women aged 40+ who 
may be disabled, self-employed, and/or have limited English proficiency (LEP).   
The CPRIT funding supported hiring four, fulltime equivalent regional cancer prevention 
specialists to work with county extension agents to organize local work groups of women to 
deliver the FTF program and educate women about the need for mammograms and Pap tests.  
However, the funding did not allow for follow-up or active support for women to obtain the 
screenings. To address these issues and increase the number of women screened, clinical services 
funding was sought and awarded by CPRIT, allowing the addition of four fulltime equivalent 
patient navigators to join the team of regional cancer prevention specialists, payment for clinical 
services when needed, and transportation services. 
The purpose of the, now, Friend to Friend plus Patient Navigation Program (FTF+PN) is 
to build an effective, sustainable infrastructure and overcome barriers to breast and cervical 
screening and diagnostic services to increase screening rates for underserved, un-/under-insured, 
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and older women in approximately 50 rural and border counties.  The goal is to increase the 
number of women screened according to American Cancer Society (ACS) guidelines for breast 
and cervical cancer, thereby increasing the probability any cancers detected would be diagnosed 
in earlier stages.   At the time, ACS guidelines recommended annual mammograms for women 
aged 40-54 and biannual mammograms for those aged 55+ with average risk of breast cancer.154  
For cervical cancer screenings, recommendations included Pap tests every 3 years for women 
aged 21-29 and every 5 years for women aged 30-65 with no additional screenings needed for 
women aged 65+ if their previous results were normal.155 
Methods 
 This prospective study analyzed program evaluation data collected from FTF+PN 
participants and events from March 1, 2012 to February 28, 2015. The Institutional Review 
Board (IRB) of The University of Texas at Austin reviewed and approved (FWA # 00002030) 
the proposed study prior to analysis.  Data included responses to pre- and post-test surveys of the 
education intervention (FTF) and follow-up surveys of screening behavior by non-PN and PN 
participants, totaling N = 2,689 unique respondents meeting inclusion criteria for the final 
analytic sample.  The sample included women aged 18 to 99, who self-identified exclusively as 
African American (AA), Latina, and NHW.  Individuals indicating multiple race/ethnicities (n = 
123), American Indian or Native American (n = 29), Asian, Asian-American, or Pacific Islander 
(n = 20), and other race/ethnicity or missing (n = 21) were excluded due to small sample sizes.  
Also, subsequent responses for women attending multiple parties (n = 346) were excluded.   
Two survey items identify Latinas.  The first asked the respondent to identify their 
race/ethnicity, with “Latino, Hispanic, Chicano, Mexican or Mexican-American, Central 
American, or other Latin American” as one response option.  The second asked about primary 
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language used at home.  Primary language use at home, conceptualized as a marker of 
acculturation, distinguished Latinas who only spoke English (Latina ES; n = 399) from those 
who only spoke Spanish or used Spanish and English equally (Latina SS; n = 1,261).  Language 
accounts for most of the explained variance in studies of acculturation measures,156 and brief, 
language-based measures of acculturation have been validated among Latino groups with 
English or Spanish language preferences.157  This variable helps to distinguish nuances among 
Latina participants using an available survey item approximating this measure.  Thus, four 
demographic groups were defined according to race/ethnicity and acculturation (AA, Latina ES, 
Latina SS, and NHW). 
 Dependent variables recorded on the follow-up surveys included PN status, receipt of 
mammogram screening, and receipt of Pap screening.  Each FTF participant was offered a “help 
request form” to indicate the need for PN and screening services following the education 
program.  Respondents providing contact information on the posttest survey and/or help request 
were subsequently interviewed by patient navigators to determine if they received a 
mammogram or Pap test.  The total number of contacts, summing the number of direct contacts 
(calls, emails, texts, etc.) with a participant and indirect contacts made on behalf of a participant 
(calls, emails, texts, etc. coordinating services with providers made by the patient navigator or 
regional cancer specialist that did not include the participant), were also noted on the follow-up 
survey.  Those not providing contact information on the posttest survey or help request and those 
who had not completed a follow-up interview were excluded from the analysis (See Table 5.1). 
Several independent variables from the pretest and posttest surveys were included in the 
analysis.  The pretest captured the respondents’ demographic data including race/ethnicity (self-
identified exclusively as AA, Latina, or NHW), primary language use at home (English only, 
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Spanish only, or English and Spanish equally), age (calculated based on year of birth), and 
education level (categorized as did not complete high school, high school graduate, or some 
college or more).  Participants also self-reported mammogram and Pap test history 
(dichotomized as receiving a mammogram or Pap test prior to FTF+PN or not) in addition to the 
main reason for attending FTF (need help paying for tests, came with friend/family member, 
family history of cancer, doctor/nurse said tests were needed) on the pretest.  Individuals 
reported barriers to screening on the posttest with options including worry about cost, 
transportation, not having time, problems with child/elder care, nervousness about testing, bad 
experiences getting care, testing not offered where they live, not knowing where to go, problems 
getting through the application process for assistance programs, or other reason.  All analyses 
were conducted using SPSS software, version 21 (IBM Corp., Armonk, NY).  Findings were 
considered statistically significant using 2-tailed P values of less than .05, .01, and .001. 
Results 
 Table 5.1 presents the number of sample participants by race/ethnicity and follow-up 
status.  NHWs were the largest group represented (45.2%) followed by Latina SS (37.5%), 
Latina ES (12.6%), and finally AAs (4.8%).  The sample was further separated by PN cases 
(27.7%), non-PN cases (37.9%), and those with no follow-up (34.5%) who either omitted contact 
information effectively closing their case or were still awaiting follow-up at the time of the 
analysis.   
 Table 5.2 provides descriptive statistics of independent variables for the two follow-up 
categories (PN and non-PN cases) by race/ethnicity.  Women aged 40 to 64 consistently 
represented the largest proportion of PN and non-PN participants in each racial/ethnic category 
reflecting the goal of FTF+PN as well as ACS guidelines for women most in need for 
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mammogram screening.154  Latina SS women reported the lowest educational achievement for 
both PN cases (63.1%) and non-PN cases (39.2%).  PN participants designated cost as the reason 
for attending at much higher rates compared to non-PN respondents.  Finally, PN participants 
received mammogram and Pap screenings after the FTF event at much higher rates compared to 
non-PN respondents.   
The logistic regression model results for odds of PN status, mammogram screening, and 
Pap screening appear in Table 5.3.  The first step of the PN hierarchical model identifies that all 
sociodemographic variables significantly impact PN status.  Older women had lower odds of 
being a PN participant, women of color had 2.4 to 8.5 higher odds of being a PN participant 
compared with NHW women, and women with lower levels of education had higher odds of 
being a PN participant compared with women with at least some college education.  The second 
step of the model includes additional screening-related variables.  Age, race/ethnicity, and 
education remained statistically significant, and respondents reporting cost of screening or that a 
health professional advised them to attend as a reason for attending a FTF+PN event had higher 
odds of being a PN participant compared with women who did not endorse those reasons. 
Women reporting a barrier to screening also had higher odds of being a PN participant compared 
with women reporting no barriers (OR = 4.42, CI = 3.30-5.93).  Finally, women reporting that 
they attended a FTF+PN event because a friend or family member was attending had lower odds 
of being a PN participant compared with women who did not endorse that reason.  
 The logistic regression models for mammogram screening follow the PN status models.  
In the sociodemographic model (Step 1), older and Latina SS women, and those with lower 
education had higher odds of receiving a mammogram compared with their respective reference 
groups.  In the second step of the model including screening-related factors, Latina SS women 
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were no longer statistically significantly different from NHW women in the odds of screening, 
but Latina ES women had lower odds of screening compared with NHW women.  Women with a 
history of a screening and those who came to FTF primarily because a doctor or nurse say that 
the test was needed had higher odds compared with women with no history and who did not 
select a doctor or nurse’s recommendation as the main reason for attending.  Cost of screening as 
a reason for participating in a FTF+PN event was associated with 1.8 higher odds of receiving a 
mammogram compared to those not endorsing that reason.  Also, both being a PN participant 
(OR = 2.64, CI = 1.02-1.91) and respondents with more contacts (OR = 1.14, CI = 1.11-1.17) 
had greater odds of receiving mammograms compared with non-PN participant status and 
women with fewer contacts. 
  Finally, Table 5.3 presents logistic regression models for getting a Pap test at follow-up 
in the last two columns.  In the sociodemographic model, older women had lower odds, and 
Latina SS women and those with lower education had higher odds of receiving a Pap test 
compared with younger, NHW, and college educated women.  Once the screening-related factors 
were added in Step 2, older women still had lower odds compared with younger women, and 
Latina SS women still had higher, although attenuated odds, compared with NHW women.  
However, Latina ES women were found to have lower odds of receiving a Pap test compared 
with NHW women and the education odds were no longer statistically significant.  As with 
mammograms, participants indicating cost as a reason for attending a FTF+PN event had higher 
odds of receiving a Pap screening (OR = 1.80, CI = 1.40-2.32) than those not endorsing this 
reason.  PN participants also had higher odds of receiving a Pap test compared to non-PN 
participants (OR = 2.72, CI = 2.00-3.69), and a greater number of contacts was associated with 
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higher odds of receiving a Pap screening compared to those with fewer contacts (OR = 1.13, CI 
= 1.10-1.17). 
 Of women in the follow-up sample who received a mammogram, 201 had an abnormal 
finding, 103 received a diagnostic screening, and 22 women were diagnosed with breast cancer.  
For Pap tests, 70 women had an abnormal finding, 14 received a diagnostic screening, and eight 
women received a cervical cancer diagnosis.  The grant provided funding for continued 
navigation and clinical services following screening if the women did not qualify for other 
programs such as Breast and Cervical Cancer Services (BCCS), Medicaid, private insurance, or 
other options. 
Discussion 
 The results of this study yield several promising findings regarding the impact of adding 
PN to the FTF health education program to increase breast and cervical cancer screening among 
women in rural Texas.  Participation in PN was associated with an increase in the odds for both 
mammogram and Pap screenings.  In addition, more contacts to the participants themselves or on 
their behalf increased the odds for screening in these same models.  These variables illustrate that 
PN status and follow-ups are clear points of intervention that can be leveraged to increase the 
likelihood of participants in FTF+PN to screen successfully for breast and cervical cancer and 
reflect similar successes reported in preventative screening PN programs.  Comparable studies 
include a promotora-based intervention that significantly increased mammograms in a 
randomized sample of 381 women living in the United States-Mexico border region of 
Arizona.44  A quasi-experimental study of 1,181 rural women in Louisiana reported higher odds 
of mammogram screening for those receiving navigation compared to women receiving health 
education only.48 
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 The FTF+PN program was successful in reaching its intended target population of 
women who are at higher risk of unfavorable breast and cervical cancer outcomes158 and who 
could benefit from PN services.  Rural women of color, those with lower education, those who 
attended FTF because of concerns about screening cost, and those reporting a barrier to 
screening had higher odds of being a PN participant compared with their reference groups.  
While ACS guidelines for mammogram and Pap tests154,155 have a limited age range compared to 
the sample, the intervention did not exclude any participants aged 18+ based on 
recommendations as women outside of these ranges may need services depending on their 
individual health status and history.  Instead, we chose to include all adults and to control for age 
for increased power and a consistent sample size.  Furthermore, this intervention leverages 
aspects of social cognitive theory that describes the role of observational learning in behavioral 
performance through positive reinforcement.159 Peer networks, including friends and family, 
model a behavior that the individual incorporates through observation into their own behavior.  
Observational learning increases self-efficacy, the individual’s belief in her ability to get 
screened for breast and cervical cancer, as these women learn from interpersonal and community 
role models.  As indicated in Table 5.3, 31-49% of women identified attendance to FTF with a 
friend or family member as the main reason for participating.  Women often attend FTF with 
friends and relatives, respond to the pre- and posttest, but may not seek screening.  Thus, these 
women have lower odds of being a PN participant.  Still, FTF educates women of all ages to 
increase health literacy of these cancers that may affect them directly or other women in their 
social networks.  In sensitivity analyses, we re-ran the logistic regression models according to 
ACS age guidelines (aged 40 years and over for mammogram screening, aged 21-65 years for 
Pap screening) and found similar results. 
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A main reason for attending FTF+PN was needing help paying for the screening(s).    
Participants had to connect with a patient navigator or regional cancer prevention specialist in 
order to pay for the screenings using the funds provided by CPRIT or from other programs of 
which participants may have been unaware, such as BCCS, other screening programs, private 
insurance, etc.  Despite mandates for full coverage of breast and cervical cancer screening costs 
under the Affordable Care Act (ACA), additional supportive services are needed to help increase 
breast and cervical cancer screening for women who remain uninsured after ACA’s 
implementation and still face cost as a barrier to screening.122  Therefore, FTF+PN is providing a 
safety net for rural, low SES women to access mammograms and Pap tests, as Medicaid 
coverage was not expanded in Texas to increase insurance coverage for the uninsured poor living 
between 101-133% of the federal poverty level (FPL).  The program aimed to provide screening 
services to un-/underinsured women; however, insurance status was not recorded systematically 
although navigators may have collected this information from some participants during their 
initial intake.  Future analyses of this data should include measures of health insurance status at 
the county-level. 
 Advice from a medical service provider has been demonstrated to increase preventative 
cancer screening.160-162  Though this variable was significant in the regression on mammogram 
screening and not for Pap screening, advice from a nurse or doctor as a reason for attending FTF 
was associated with nearly a threefold increased odds (OR = 2.54) in choosing PN (see Table 
5.3).  This finding highlights the impact of medical provider advice on shaping screening 
behavior by increasing the readiness of these women to take a step towards screening.  
Consequently, medical providers must be aware of current prevention recommendations in order 
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to provide accurate health education to their patients based on risk factors including age and 
family history.  This duty is compounded by the evolving nature of the recommendations. 
Latina ES women experienced higher odds of PN status and lower odds of receipt of a 
mammogram or a Pap test compared to NHWs after controlling for other important 
sociodemographic and screening-related factors.  These findings are in contrast with the 
experience of Latina SS women, who also had higher odds of PN status, but no differences in 
receipt of a mammogram, and higher odds of a Pap screening compared to NHWs.  Separate 
logistic regressions were also conducted with Latina SS as the reference group to compare the 
outcomes between Latina ES and SS women directly (see Table 5.4).  This positive finding for 
less acculturated Latinas is important to highlight as Latinas experience much higher incidence 
and mortality rates of cervical cancer compared to other groups in Texas; further, this finding 
appears to substantiate the “Hispanic paradox” theorized as the protective effect of immigration 
on health as less acculturated Latinos born outside the U.S. consistently exhibit lower morbidity 
and mortality compared to U.S. born Latinos and NHWs.1  However, data regarding country of 
origin and time living in the U.S. was not collected from this sample; thus, this effect can only be 
suggested by the limited measure of acculturation based on language. Although the FTF+PN data 
cannot differentiate Latinas into heterogeneous subgroups, census data indicate 87% of Latinas 
in Texas are of Mexican origin.163  It may be possible that regional differences in PN efforts and 
providers may have accounted for the differences, or that the PNs were more successful at 
navigating SS women compared with ES women for reasons that would require further research. 
While AAs experienced greater odds of PN status compared to NHWs, there was no 
significant difference in their receipt of mammogram or Pap screening compared to NHWs in the 
adjusted models, indicating that navigation was successful for these women, or at least as 
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successful as it was for NHWs.  While not considered in the statistical analysis, the success in 
screening AA women may be due in part to racially and culturally congruent intervention staff 
able to reach women in their community.  This finding demonstrates the success of the 
intervention considering observational studies that indicate lower breast and cervical cancer 
screening rates for AA women compared to NHW women after controlling for 
sociodemographic variables in both urban37 and rural164 settings.  Other population-based165 and 
rural166 studies point to lower screening rates and later stage breast cancer diagnosis for AA 
women compared to NHWs. 
The results of this study include several limitations.  First, the study sample is non-
representative as there was a concerted effort to target women who were lower SES, and un- or 
under-insured.  There is no way to determine whether the FTF+PN sample is representative of all 
lower SES and un-/under-insured women in these rural counties.  All evaluation instruments 
recorded information based on self-report with possible recall bias a potential limitation.  As 
noted in Table 5.1, 35% of the FTF+PN participants had not completed a follow-up interview, 
though comparisons of these respondents with those in the follow-up sample did not reveal any 
substantial differences.  Also, program implementation differed in each of the four regions.  The 
role of the patient navigator and cancer prevention program specialist varied by region, and 
protocols of when and how to follow-up may not have been consistent across regions.  Ideally, 
the study aimed to measure time from FTF participation to screening; however, delays in 
contracts with providers and protocol variations threatened measurement fidelity of this variable.  
Finally, we had a very limited measurement of SES (i.e., educational attainment) in our study.  
We were unable to examine other measures, such as income, wealth, and/or occupational status. 
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Despite these limitations, the study includes a large sample of women living in rural and 
border areas within the second largest state by area and population in the U.S.  Given the large 
Spanish-speaking population involved in the study, the FTF+PN program and survey materials 
were available in Spanish.  Furthermore, several of the patient navigators and program assistants 
are bilingual to assist monolingual Spanish speakers and bilingual Spanish speakers with LEP. 
The data from the evaluation of FTF+PN lends itself to further analysis in order to 
determine additional factors that may be related to breast and cervical cancer screening outcomes 
for this sample.  This analysis lays the groundwork for future studies nesting participants by 
county and region to develop a multilevel model testing the effects of ecological variables on PN 
participation and mammogram and Pap screening outcomes.  
Conclusion 
 PN is an effective intervention approach to increase breast and cervical cancer screening 
among women in rural and border Texas.  The study’s findings add to the evidence base that 
demonstrate the positive impact of PN on mammograms and Pap tests in varied settings across 
the U.S.  The analyses suggest that FTF+PN successfully captures participants who are 
underrepresented in breast and cervical preventative screening (rural women, women of color) 
and suffer poorer cancer-related outcomes. 
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Table 5.1   
Friend to Friend + Patient Navigation participants, 3/1/12-2/28/15, by race/ethnicity and follow-up status (N 
=4,104) 
 Follow-up    No follow-up  Total, n (%) 
Race/ethnicity PN cases  Non-PN cases     
African American  43 60  92  195 (4.8) 
Latina English Speaking  205 194  119  518 (12.6) 
Latina Spanish Speaking 1,076 185  276  1,537 (37.5) 
Non-Hispanic White 230 696  928  1,854 (45.2) 
Total, n (%) 1,554 (37.9) 1,135 (27.7)  1,415 (34.5)  4,104 (100.0) 
PN=patient navigation 
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Table 5.2  
Characteristics of patient navigation (PN) and non-patient navigation (non-PN) follow-up respondents of Friend to Friend + Patient Navigation, 3/1/12-2/28/15 
(N =2,689) 
 PN follow-up cases  Non-PN follow-up cases 
Variable AA Latina ES Latina SS NHW  AA Latina ES Latina SS NHW 
Race/ethnicity (n) 43 205 1,076 230  60 194 185 696 
Age category (%)          
   18-29 years 11.6 12.1 5.7 6.5  0.0 10.7 10.7 4.1 
   30-39 years 11.6 19.1 17.7 12.6  0.0 17.6 20.3 10.6 
   40-64 years 72.1 61.8 71.7 68.7  61.8 58.8 44.1 49.5 
   65+ years 4.7 7.0 4.9 12.2  38.2 12.8 24.9 35.8 
Education level (%)          
   Did not complete high school 11.6 19.0 63.1 21.0  13.3 9.6 39.2 3.7 
   High school graduate or GED 44.2 36.5 24.4 31.1  28.3 31.9 26.5 23.8 
   Some college or more 44.2 44.5 12.5 47.9  58.3 58.5 34.3 72.5 
Screening history 
   Reported mammogram prior to FTF (% Yes) 
 
51.2 
 
55.4 
 
58.4 
 
63.3 
  
91.5 
 
68.9 
 
64.4 
 
80.5 
   Reported Pap prior to FTF (% Yes) 73.8 91.7 88.5 90.7  86.7 93.3 85.0 92.9 
Main reason for attending FTF:          
   Need help paying for tests (% Yes) 55.8 68.8 77.6 60.4  1.7 8.2 21.6 5.5 
   Came with friend/family member (% Yes) 34.9 31.2 33.1 32.6  35.0 35.6 49.2 39.2 
   Family history of cancer (% Yes) 34.9 39.0 28.2 41.3  38.3 24.7 27.6 32.0 
   Doctor/nurse said tests were needed (% Yes) 14.0 13.2 20.0 10.0  1.7 3.1 2.7 2.3 
   To find out more about tests (% Yes) 25.6 31.7 49.0 31.3  38.3 39.7 42.7 21.6 
Reported barrier to screening (% Yes) 86.0 92.2 90.4 85.2  40.0 52.6 52.4 43.7 
Number of contacts (Mean) 8.2 8.4 9.3 5.5  2.2 2.6 2.6 2.5 
Received mammogram screening (% Yes)a 55.8 44.9 60.4 39.1  15.0 10.8 9.7 28.0 
Received Pap screening (% Yes)a 51.2 48.3 68.9 33.9  6.7 6.2 8.6 16.1 
 
Note. Percentages based on total number of responses received by each racial/ethnic group for each item. AA=African American; ES=English speaking; 
SS=Spanish Speaking; NHW=non-Hispanic White. 
a Depending on the help request, some received both mammogram and Pap tests, while others only received one screening. 
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Table 5.3   
Odds of patient navigation status, mammogram screening, and Papanicolaou (Pap) screening among follow-up respondents, Friend to Friend + Patient Navigation, 
3/1/12-2/28/15 (N =2,689) 
 Patient Navigation Status Mammogram Screening Pap Screening 
 Step 1 Step 2 Step 1 Step 2 Step 1 Step 2 
Variable OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Age 0.97 (0.96-0.98)*** 0.97 (0.97-0.99)*** 1.03 (1.03-1.04)*** 1.04 (1.03-1.05)*** 0.98 (0.97-0.99)*** 0.99 (0.98-1.00)* 
Race/Ethnicity       
   African American  2.38 (1.51-3.76)*** 3.03 (1.74-5.29)*** 1.23 (0.75-2.03) 0.91 (0.52-1.57) 1.54 (0.92-2.58) 1.03 (0.57-1.86) 
   Latina English Speaking  2.36 (1.80-3.09)*** 1.99 (1.42-2.79)*** 1.08 (0.81-1.45) 0.60 (0.43-0.83)** 1.23 (0.92-1.65) 0.66 (0.47-0.92)* 
   Latina Spanish Speaking 8.48 (6.57-10.94)*** 6.77 (4.91-9.35)*** 2.53 (1.98-3.22)*** 0.93 (0.69-1.25) 4.15 (3.24-5.31)*** 1.64 (1.22-2.20)** 
   Non-Hispanic White ref. ref. ref. ref. ref. ref. 
Education level       
   Did not complete high school 4.58 (3.46-6.07)*** 2.39 (1.68-3.39)*** 1.94 (1.52-2.47)*** 1.25 (0.94-1.65) 1.64 (1.28-2.11)*** 0.88 (0.66-1.17) 
   High school graduate or GED 2.21 (1.74-2.79)*** 1.59 (1.18-2.13)** 1.35 (1.08-1.70)* 1.01 (0.78-1.31) 1.29 (1.02-1.63)* 0.87 (0.66-1.14) 
   Some college or more ref. ref. ref. ref. ref. ref. 
Reported mammogram prior to 
FTF 
 1.10 (0.79-1.52)  2.29 (1.80-2.92)***   
Reported Pap prior to FTF  0.92 (0.59-1.42)    1.36 (0.96-1.91) 
Main reason for attending FTF:       
   Need help paying for tests  11.84 (8.87-15.81)***  1.75 (1.35-2.28)***  1.80 (1.40-2.32)*** 
   Came with friend/family 
member 
 0.73 (0.57-0.95)*  0.91 (0.74-1.11)  0.89 (0.72-1.10) 
   Family history of cancer  1.14 (0.87-1.49)  0.94 (0.77-1.16)  0.99 (0.80-1.23) 
   Doctor/nurse said tests were 
needed 
 2.54 (1.43-4.53)**  1.39 (1.02-1.91)*  1.09 (0.79-1.49) 
   To find out more about tests  0.95 (0.73-1.24)  1.09 (0.88-1.34)  1.02 (0.83-1.26) 
Reported a barrier to screening  4.42 (3.30-5.93)***  0.97 (0.75-1.27)  1.21 (0.91-1.60) 
Patient navigation status (PN v. 
non-PN) 
   2.64 (1.93-3.60)***  2.72 (2.00-3.69)*** 
Number of contacts    1.14 (1.11-1.17)***  1.13 (1.10-1.17)*** 
*P < .05, **P < .01, ***P < .001 
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Table 5.4   
Odds of patient navigation status, mammogram screening, and Papanicolaou (Pap) screening among follow-up respondents, Friend to Friend + Patient 
Navigation with Latina Spanish Speaking as the reference group, 3/1/12-2/28/15 (N =2,689) 
 Patient Navigation Status Mammogram Screening Pap Screening 
 OR (95% CI) OR (95% CI) OR (95% CI) 
Age 0.97 (0.97-0.99)*** 1.04 (1.03-1.05)*** 0.99 (0.98-1.00)* 
Race/Ethnicity    
   African American  0.45 (0.25-0.79)** 0.98 (0.56-1.71) 0.63 (0.35-1.13) 
   Latina English Speaking  1.99 (1.42-2.79)*** 0.64 (0.47-0.89)** 0.40 (0.29-0.55)*** 
   Non-Hispanic White 6.77 (4.91-9.35)*** 1.08 (0.80-1.45) 0.61 (0.46-0.82)** 
   Latina Spanish Speaking ref. ref. ref. 
Education level    
   Did not complete high school 2.39 (1.68-3.39)*** 1.25 (0.94-1.65) 0.88 (0.66-1.17) 
   High school graduate or GED 1.59 (1.18-2.13)** 1.01 (0.78-1.31) 0.87 (0.66-1.14) 
   Some college or more ref. ref. ref. 
Reported mammogram prior to FTF 1.10 (0.79-1.52) 2.29 (1.80-2.92)***  
Reported Pap prior to FTF 0.92 (0.59-1.42) - 1.36 (0.96-1.91) 
Main reason for attending FTF:    
   Need help paying for tests 11.84 (8.87-15.81)*** 1.75 (1.35-2.28)*** 1.80 (1.40-2.32)*** 
   Came with friend/family member 0.73 (0.57-0.95)* 0.91 (0.74-1.11) 0.89 (0.72-1.10) 
   Family history of cancer 1.14 (0.87-1.49) 0.94 (0.77-1.16) 0.99 (0.80-1.23) 
   Doctor/nurse said tests were needed 2.54 (1.43-4.53)** 1.39 (1.02-1.91)* 1.09 (0.79-1.49) 
   To find out more about tests 0.95 (0.73-1.24) 1.09 (0.88-1.34) 1.02 (0.83-1.26) 
Reported a barrier to screening 4.42 (3.30-5.93)*** 0.97 (0.75-1.27) 1.21 (0.91-1.60) 
Patient navigation status (PN v. non-PN)  2.64 (1.93-3.60)*** 2.72 (2.00-3.69)*** 
Number of contacts  1.14 (1.11-1.17)*** 1.13 (1.10-1.17)*** 
*P < .05, **P < .01, ***P < .001 
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Paper 2:  County-level Poverty and Barriers to Breast and Cervical Cancer Screening in a 
Health Education and Patient Navigation Intervention for Rural and Border Texas 
Residents 
Introduction 
 Breast and cervical cancers broadly impact women’s health with more than 280,000 new 
diagnoses and nearly 46,000 cancer-related deaths reported in 2018,167 yet social determinants 
affect morbidity and mortality outcomes differently for varying groups of women.168  For 
example, rural women’s lower screening rates compared to urban residents’ rates may lead to 
later stage diagnoses and higher mortality rates for both types of cancer.3,5  Even more, women in 
rural counties with high poverty rates screen for breast cancer at much lower rates than their 
urban counterparts, and these differences are compounded for women of color when compared to 
urban and white residents.169  Studies of residents living in the Texas-Mexico border region 
reflect similar findings with lower cancer screening and higher cancer-related mortality in lower 
socioeconomic status (SES) areas compared to higher SES areas with additional variation by 
race/ethnicity favoring NHW women.169,170  Other comparisons of racial/ethnic groups 
demonstrate higher breast cancer mortality rates for African American (AA) women than for 
non-Hispanic white (NHW) women and higher cervical cancer mortality rates for both AA and 
Latina women than for NHW women associated with differences in access to screening and 
high-quality cancer care, varying rates of poverty, access to insurance, longer follow-up for 
diagnosis and treatment, among other possible factors.168  As a result of these findings, targeted 
cancer care delivery beginning with detection has resulted in interventions for un-/underserved 
women with the goal of connecting them to timely care to improve both individual and 
population outcomes.2 
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 In 2012, the Texas Agrilife Extension Service established Friend to Friend plus Patient 
Navigation (FTF+PN) with grant funds from the Cancer Prevention Research Institute of Texas 
(CPRIT) to increase breast and cervical cancer screening among women aged 40+ who may be 
disabled, self-employed, and/or have limited English proficiency (LEP) residing in 
approximately 70 un-/underserved rural and border counties.  Grant funds paid for clinical 
services and employed four trained, lay patient navigators that joined an established team of four 
regional cancer specialists to follow-up with program participants and provide transportation or 
other ancillary services that addressed barriers that might prevent women from screening.  
Patient navigators and regional cancer specialists worked in four regional teams where they 
organized bilingual, culturally sensitive cancer education incorporating local cancer care 
professionals and survivors from the community.  The education program known as a “pink 
party” informed women about the need for timely breast and cervical cancer screening based on 
American Cancer Society (ACS) guidelines for breast and cervical cancer at the time 
recommending annual mammograms for women aged 40-54 and biannual mammograms for 
those aged 55+ with average risk of breast cancer154 and Papanicolaou (Pap) tests every 3 years 
for women aged 21-29 and every 5 years for women aged 30-64.155  Women attending the party 
were offered help getting screened at the end of the event using PN services to assist them with 
payment, transportation, or barriers that might prevent them from screening.  Participants who 
provided contact information at any point during the intervention received follow-up interviews 
to assess their screening outcomes. 
 The following analysis examined the impact of county-level poverty rates on screening 
outcomes for participants attending the FTF events and reporting a barrier to screening.  In doing 
so, it examines the intervention’s capacity to identify and connect individuals residing in the 
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poorest communities to screening services.  By addressing both individual and community needs 
that may negatively impact screening outcomes, FTF+PN seeks to impact cancer-related 
outcomes for disadvantaged rural and border residents of Texas. 
Methods 
The analysis combines the proportion of adults living at or below the federal poverty 
level (FPL) for each county with individual-level variables from FTF+PN participants who 
attended the FTF and reported at least one barrier to screening.  FTF+PN was implemented in 36 
rural and border counties during 2012, and the following year saw an additional 23 counties 
served.  In 2014, 5 more counties received the intervention for the first time.  Finally, 7 novel 
counties were included in the program in 2015 and 5 more in 2016.  Based on availability and 
demand, some counties had multiple parties within the same year and some held additional in 
subsequent years.   In total, FTF+PN operated in 76 unique counties within four administrative 
regions and held over 180 separate FTF events from 2012 to 2016.   
The individual-level data include responses to pre- and post-test surveys from FTF+PN 
participants during events and follow-up surveys of screening behavior from March 1, 2012 to 
November 5, 2016, totaling N=7,450 unique observations.  The analytic sample first excluded 
women who had not received follow-up (n=1,451) as their screening status could not be 
determined.  Women who did not report barriers to screening (n=1,667) were also excluded.  In 
addition, 96 respondents reporting multiple or other racial/ethnic categories, women who 
identified as American Indian or Native American (n=29), Asian, Asian-American, or Pacific 
Islander (n=30), were excluded due to small sample sizes. Latinas were divided into two groups 
based on their language preference at home; therefore, those that spoke something different than 
English or Spanish (n=6) or missing this variable (n=50) were removed. Surveys with missing 
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age (n=95) and education level (n=189) were excluded.  Finally, 545 participants who had 
attended repeated events were excluded for a total of N=3,292 included in the analytic sample.  
The Institutional Review Board (IRB) of The University of Texas at Austin reviewed and 
approved (FWA # 00002030) the proposed study prior to analysis. 
Theoretical Framework 
 Andersen’s behavioral model of health service utilization guides the conceptualization of 
this study to explain factors related to mammogram and Pap screening among intervention 
participants.  The model describes the relationships among environmental and population 
characteristics that determine level of engagement with healthcare and subsequent health 
outcomes.171  Environmental factors include access to the healthcare system, availability of 
health services, and the external environment.172  Population characteristics describe 
predisposing characteristics (e.g., age and race/ethnicity), individual and community enabling 
resources, and both perceived and actual need.172  Mutability, or the degree to which these 
factors can be influenced to effect behavioral change, also plays a key role in the model 
design.171 
Measures 
County-level variables.  The U.S. Census Bureau supplied aggregated data from the 
2014 American Community Survey for county-level measure of poverty.163  Percentages of the 
adult county population aged 18+ who lived below the FPL comprised the area SES measure.  
This variable was divided into tertiles ranked as low, medium, or high relative to the other 
counties involved in the intervention.  Previous studies have found that residents of high poverty 
areas are diagnosed with more advanced stage cancer and have increased mortality from various 
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types of cancers including cervical and breast.4  More specifically, women in high poverty 
neighborhoods appear to have increased risk for cancer-related death underscoring the need for 
increased cancer screening in these areas.173  Thus, this measure assesses FTF+PN participants’ 
screening behavior relative to their residential location.  Finally, the program operated in four 
administrative regions of the state (North, South, East, or West) adding an additional 
organizational level to the data. 
Individual-level variables.  The dependent variable consists of FTF+PN follow-up 
participants’ receipt of a mammogram and/or Pap screening following the intervention.  For the 
mammogram outcome, only women aged 40+ were included in the analysis based on ACS 
recommendations for an analytic sample of N=2,326.  The Pap screening outcome sample was 
similarly reduced to women aged 21-64 based on ACS recommendations for a total of N=2,959 
participants.  Respondents provided demographic data including age (determined from their year 
of birth), race/ethnicity, primary language use at home, and education level (options included did 
not complete high school, high school graduate, or some college or more).  Participants self-
identified their racial/ethnic identity as AA, Latina, or NHW.  Primary language use at home was 
defined as those who spoke English only, Spanish only, or English and Spanish equally.  This 
variable was used to differentiate English speaking Latina (ESL) women from Spanish speaking 
Latina (SSL) women.  Participants indicated if cost was the main reason for attending FTF, and 
their patient navigation status was recorded during follow-up interviews.  The posttest captured 
potential barriers to screening with options including worry about cost, transportation, not having 
time, problems with child/elder care, nervousness about testing, bad experiences getting care, 
testing not offered where they live, not knowing where to go, problems getting through the 
application process for assistance programs, or other reason.  This variable was used to select 
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those who reported a barrier to screening while excluding women who did not report any barrier 
from the analysis. 
Statistical Analysis 
The primary statistical analyses consisted of multilevel regression models using PROC 
GLIMMIX in SAS 9.4 (SAS Institute, Cary, NC).  A series of logistic regression models analyze 
mammogram and Pap screening completion separately using fixed and random effects of 
individual and county level data. First, an intercept only model is used to calculate between-
county variance.  Then, fixed effects including age, race/ethnicity/language, and education level 
are added to the model.  The next models include not attending FTF due to cost of screening, and 
not participating in PN.  Finally, the county-level poverty ranking is considered in the final 
models. 
Results 
Results from the univariate analyses showed that mammogram and Pap screening 
prevalence rates were highest among women aged 40-64, SSL, and lower educated women as 
noted in Table 5.5.  Over 41% of women with barriers did not attend the education intervention 
due to the cost of screening, and 26% of the sample chose not to participate in PN.  Residents of 
counties with more than 19.2% of adults living in poverty represented the largest portion of the 
sample and had the highest screening prevalence rates for both tests.  Similarly, the South region 
experienced the highest prevalence rates for both screenings and represented the largest portion 
of the sample. 
The interclass correlation coefficients (ICCs) indicated significant variability in screening 
rates by county (results not shown).  For mammogram screening, 3.29 was used as the level-1 
  
65 
 
error variance174 and the county-level error variance was 0.84 for an ICC = 
0.84
0.84+3.29
 = 20%.  For 
Pap screening, the county-level error variance was 0.89 for an ICC = 
0.89
0.89+3.29
 = 21%.  Table 5.6 
reported the results of the subsequent models with the added effects.  Model 1 began with 
demographic variables including age, race/ethnicity/language categories, and education level.  In 
the first model, AA and ESL women reporting a barrier to screening both experienced lower 
odds of screening with a mammogram compared to NHW women.  This finding persisted across 
all models.  Similarly, age and education level do not significantly impact any of the models. 
In Model 2, two program related variables, not attending FTF due to cost of screening 
and not being a PN recipient, were included.  This model revealed that women with barriers who 
were not concerned about cost and who did not participate also experienced lower odds of 
getting screened.  Finally, the last model includes the county-level poverty variable which did 
not contribute any more to the model from the previous version.  The model also increased the -2 
log-likelihood statistic, indicating that the poverty level variable did not improve the model fit. 
Table 5.7 reported the Pap screening models using the same progression of added effects.  
In the first, only education played a significant role with lower educated women with a barrier to 
screening experiencing higher odds than college educated women.  However, this finding did not 
persist in Models 2 and 3, where women with barriers not attending FTF due to the cost of 
screening and not being a PN participant both had reduced odds of receiving a Pap screening.  In 
addition, the last model indicated that counties with lower poverty rates experienced nearly 
double the odds of screening for cervical cancer compared to higher poverty counties. 
Discussion 
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 The findings from this study affirm PN as an effective intervention to increase screening 
uptake for both breast and cervical cancer.  While individual-level variables indicated areas of 
programmatic success and specific groups of women still opting not to screen, the county-level 
results were less clear.  For mammogram screening, variation based on county-level poverty did 
not appear to matter to screening outcomes despite county-level variability remaining significant 
in the model.  On the other hand, Pap screening was higher in counties with fewer adults living 
in poverty, consistent with findings from other studies demonstrating the screening advantage for 
higher SES areas.169   
 Despite their variation, the counties are high poverty in general, leading to less variation 
from county-to-county among higher SES, urban counties.  The intervention’s ability to maintain 
consistent screening rates across these boundaries, as is the case with mammograms, also speaks 
to the program’s success of changing observed screening patterns in other studies demonstrating 
the advantages of higher SES areas.  Thus, the lack of significant differences also points towards 
greater equity in screening provision among counties. 
 Finally, the results substantiate PN’s effectiveness at increasing screening rates among 
this sample, especially among women concerned about the cost for screening.  Mitigating 
financial barriers to care facilitated significant gains in screening rates among women with 
barriers to screening.  PN factors directly into this finding as patient navigators facilitated 
payment for screening services and served other needs, such as transportation.  Thus, PN practice 
in rural and border areas provides a responsive intervention to bridge gaps between health care 
systems and residents in need of cancer care services. 
 However, broad implementation of PN faces many challenges.  First, PN services require 
funding from non-traditional sources as these services are not usually covered by health 
  
67 
 
insurance further straining resource limited safety net providers already struggling with reduced 
payments for reimbursable services.175  Rural hospitals also contend with growing closures due 
to financial shortfalls further risking access to care among socioeconomically disadvantaged and 
racially/ethnically diverse communities.176  While accreditation standards reflect the evidence 
base supporting PN by benchmarking best practices in cancer care, only institutions with the 
capacity to absorb the additional cost of PN can hope to adhere to this level of care.177  
Furthermore, shortages in cancer care professionals, rising treatment costs, and higher incidence 
rates of cancers among an expanding and aging population pose even greater challenges to health 
care systems required to respond with innovative practices while struggling to maintain their 
current capacity.178 
 Despite PN’s focus on the navigator as the primary means of intervening with patients, 
PN has also been described as a system of care involving both professionals in the cancer care 
community and outside the bounds of a health care institution.113  Consequently, the various 
individuals involved in PN and cancer care must understand their role as a part of PN to achieve 
the best outcomes for individual patients and the population.  Multidisciplinary education for 
health professionals led by social workers, for example, offers a means to enhance clinical 
practice areas where the primary focus is not on treating psychosocial contributions to health and 
wellbeing but are often the primary professional contact for patients seeking screening and 
cancer treatment.82  By educating the health care workforce collaboratively, clinical 
professionals understand the role that allied professionals can contribute to reducing disparate 
outcomes from un-/underserved groups and leverage these resources to address barriers to care 
without diminishing their specific areas of expertise. 
Limitations 
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 While this study attempted to include multilevel factors influencing screening behavior, 
other elements not assessed in Andersen’s model may also account for differences in screening 
by residential location, race/ethnicity/language, and other measures.  Program implementation 
protocols varied by region so that patient navigators and regional cancer specialists could adapt 
to local conditions.  Consequently, these differences may affect screening and participation rates 
in ways not assessed in this study as noted by the outcomes in the South region.  At the time of 
the analysis, follow-up interviews had not been conducted on all intervention participants leading 
to possible bias in the results (see Table 5.8).  Follow-up procedures varied from region to region 
leading to differences in follow-up screening rates.  For example, the South region’s additional 
patient navigator adding to their capacity to perform follow-up interviews at higher rates than the 
other regions.  Also, participants from year 1 had a much longer timeframe to receive follow-up 
compared to participants in later years.  Consequently, these practical limitations may have 
affected the results of the study. 
Conclusion  
Women with known barriers face multifaceted challenges to screening for breast and 
cervical cancer often leading to negative outcomes for the un-/underserved.  Programs such as 
FTF+PN offer education and firsthand assistance for women to overcome these barriers to 
preventative care.  This help extends to communities in need such as higher poverty counties in 
rural and border areas that benefit from these services.  Still, not all participants benefitted 
equally as AA and ESL women screened lower for breast cancer than NHW women highlighting 
the need for further investigation into their screening decisions and barriers to care.  To 
conclude, screening decisions are impacted by both individual and contextual factors that 
distinguish screening behavior among varying groups of women, and both should be considered 
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in the design and implementation of interventions aiming to improve health outcomes for un-
/underserved groups.   
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Table 5.5 
Sample distribution, mammogram, and Papanicolaou (Pap) screening prevalence rates of Friend to Friend + 
Patient Navigation follow-up respondents reporting one or more barriers to screening, 3/1/12-11/5/16. 
 
 
Variable 
 
 
Full sample (%) 
 Prevalence of 
mammogram 
screening (%) 
  
Prevalence of Pap 
screening (%) 
 N=3,292  N=2,326  N=2,959 
Age      
   21-39 years 28.5  -  46.8 
   40-64 years 62.4  56.4  48.4 
   65+ years 9.1  34.1  - 
Race/ethnicity/language      
  African American 4.0  34.6  26.0 
  English Speaking Latina 13.7  39.1  35.9 
  Spanish Speaking Latina 55.5  66.4  61.1 
  Non-Hispanic White 26.8  39.0  25.8 
Education level      
   Did not complete high school 38.4  64.6  59.3 
   High school graduate or GED 27.7  52.4  49.1 
   Some college or more 33.9  41.3  32.5 
Region      
  North 22.4  32.7  20.0 
  East 13.6  43.9  27.7 
  West 12.8  44.1  30.5 
  South 51.2  68.6  67.7 
Did not attend FTF due to cost of screening 41.1  36.2  27.5 
Not a patient navigation recipient 25.5  25.6  16.3 
% county residents living in poverty       
   1st tertile, <14.2 19.3  41.5  39.0 
   2nd tertile, 14.2-<19.5 19.7  37.5  28.8 
   3rd tertile, 19.5+ 61.0  62.3  56.2 
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Table 5.6 
Mammogram screening models for Friend to Friend + Patient Navigation follow-up respondents aged 40+ reporting a barrier to screening (N=2,326), 3/1/12-
11/5/16. 
 Model 1 Model 2 Model 3 
Fixed effects Odds Ratio 95% CI Odds Ratio 95% CI Odds Ratio 95% CI 
Intercept       
Age       
   40-64 years ref.  ref.  ref.  
   65+ years 0.76 0.57-1.02 0.94 0.70-1.27 0.94 0.70-1.27 
Race/ethnicity/language       
  African American 0.58* 0.36-0.93 0.58* 0.36-0.95 0.58* 0.35-0.94 
  English Speaking Latina 0.66* 0.46-0.94 0.59** 0.41-0.85 0.58** 0.41-0.83 
  Spanish Speaking Latina 1.13 0.83-1.55 0.97 0.71-1.33 0.96 0.70-1.31 
  Non-Hispanic White ref.  ref.  ref.  
Education level       
   Did not complete high school 1.29 0.99-1.68 1.18 0.90-1.53 1.18 0.91-1.54 
   High school graduate or GED 1.16 0.91-1.47 1.08 0.84-1.38 1.08 0.85-1.38 
   Some college or more ref.  ref.  ref.  
Reason for attending FTF       
  Not due to cost of screening   0.71** 0.56-0.90 0.71** 0.56-0.90 
  Due to cost of screening   ref.  ref.  
Patient navigation participant       
  No   0.52*** 0.39-0.70 0.53*** 0.39-0.71 
  Yes   ref.  ref.  
% county residents living in poverty        
   1st tertile, <14.2     ref.  
   2nd tertile, 14.2-<19.5     1.07 0.62-1.86 
   3rd tertile, 19.5+     1.36 0.80-2.32 
       
Error variance (estimate, standard error)       
Region 0.05 (0.10)  0.02 (0.06)  0.01 (0.05)  
Region (county) 0.71*** (0.19)  0.52** (0.15)  0.53** (0.16)  
Level 1 0.97*** (0.03)  0.97*** (0.03)  0.97*** (0.03)  
Model fit       
-2 log-likelihood 10430.70  10464.43  10472.35  
*P < .05, **P < .01, ***P < .001 
 
  
72 
 
Table 5.7  
Papanicolaou (Pap) screening models for Friend to Friend + Patient Navigation follow-up respondents aged 21-64 reporting a barrier to screening (N=2,959), 
3/1/12-11/5/16. 
 Model 1 Model 2 Model 3 
Fixed effects Odds Ratio 95% CI Odds Ratio 95% CI Odds Ratio 95% CI 
Age       
   40-64 years ref.  ref.  ref.  
   65+ years 1.17 0.97-1.40 1.13 0.94-1.36 1.13 0.94-1.36 
Race/ethnicity/language       
  African American 0.61 0.35-1.04 0.62 0.36-1.07 0.63 0.36-1.09 
  English Speaking Latina 0.76 0.54-1.07 0.71 0.50-1.01 0.73 0.51-1.03 
  Spanish Speaking Latina 1.11 0.82-1.50 0.99 0.73-1.35 1.02 0.74-1.39 
  Non-Hispanic White ref.  ref.  ref.  
Education level       
   Did not complete high school 1.28* 1.01-1.62 1.17 0.92-1.49 1.17 0.92-1.49 
   High school graduate or GED 1.28* 1.02-1.61 1.17 0.92-1.48 1.17 0.93-1.48 
   Some college or more ref.  ref.  ref.  
Reason for attending FTF       
  Not due to cost of screening   0.57*** 0.46-0.70 0.57*** 0.46-0.70 
  Due to cost of screening   ref.  ref.  
Patient navigation participant       
  No   0.72* 0.53-0.97 0.70* 0.52-0.95 
  Yes   ref.  ref.  
% county residents living in poverty        
   1st tertile, <14.2     1.94* 1.02-3.71 
   2nd tertile, 14.2-<19.5     1.26 0.70-2.27 
   3rd tertile, 19.5+     ref.  
       
Error variance (estimate, standard error)       
Region 0.30 (0.32)  0.27 (0.29)  0.45 (0.44)  
Region (county) 0.82*** (0.21)  0.67*** (0.18)  0.65*** (0.18)  
Level 1 0.96*** (0.03)  0.97*** (0.02)  0.97*** (0.03)  
Model fit       
-2 log-likelihood 13577.19  13654.48  13666.86  
*P < .05, **P < .01, ***P < .001 
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Table 5.8  
Chi square tests comparing the proportions of Friend to Friend plus Patient Navigation participants without follow-up interviews to participants with follow-up 
interviews reporting barriers to screening (n=4,743), 3/1/12-11/5/16. 
Variable No follow-up (n, %)  Follow-up (n, %)  P 
Total 1,451  3,292   
Age      
   21-39 years 271, 19.7  929, 28.5  <.0001 
   40-64 years 657, 47.9  2,030, 62.4   
   65+ years 445, 32.4  296, 9.1   
Race/ethnicity/language (%)      
  African American 101, 7.2  133, 4.0  <.0001 
  English Speaking Latina 100, 7.2  450, 13.7   
  Spanish Speaking Latina 252, 18.0  1,826, 55.5   
  Non-Hispanic White 945, 67.6  882, 26.8   
Education level (%)      
   Did not complete high school 168, 12.0  1,264, 38.4  <.0001 
   High school graduate or GED 370, 26.5  911, 27.7   
   Some college or more 858, 61.5  1,116, 33.9   
Region      
  North 492, 33.9  736, 22.4  <.0001 
  East 543, 37.4  447, 13.6   
  West 236, 16.3  422, 12.8   
  South 180, 9.7  1,686, 90.4   
Attended FTF due to cost of screening 194, 13.4  1,939, 58.9  <.0001 
Did not attend FTF due to cost of screening 1,257, 86.6  1,352, 41.1   
% county residents living in poverty       
   1st tertile, <14.2 363, 25.0  635, 19.3  <.0001 
   2nd tertile, 14.2-<19.5 461, 31.8  649, 19.7   
   3rd tertile, 19.5+ 627, 43.2  2,007, 61.0   
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Paper 3: The Impact of Educational Attainment on Breast and Cervical Cancer Screening 
Outcomes Among Rural and Border Texas Women Participating in a Patient Navigation 
Intervention 
Introduction 
While racial and ethnic categories provide an essential framework for analyzing variation 
in health outcomes among a population, measures of socioeconomic status (SES) contribute to 
more nuanced understanding of health disparities both between and within racial and ethnic 
groups.179  More specifically, education has provided the strongest evidence of direct and 
indirect effects on mortality in relation to several diseases, including cancer, after controlling for 
other SES measures such as occupation and income.180 Analyses of educational attainment in 
relation to breast and cervical cancer screening substantiate the relationship between education 
and adherent screening behavior181,182 with further evidence pointing to those attaining the 
highest education levels benefitting the most from preventative screening.183   
Higher educational attainment, however, does not invariably translate into better health 
outcomes as other research describes “diminishing returns” whereby socially disadvantaged 
groups benefit from more education but still maintain poorer outcomes compared to their 
socially advantaged counterparts.184  For example, more education gives increasingly better 
health returns such as higher rates of cancer screening, but these findings are highest for Non-
Hispanic whites (NHW) and diminish to lower rates of return for other groups, such as African 
Americans (AA), despite higher educational attainment maintaining some benefit for both 
groups.  A nationally representative study of breast and cervical cancer screening supports this 
hypothesis finding evidence of an SES gradient increasing with screening rates while NHW 
women experienced more pronounced increases in screening rates due to higher SES indicators, 
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including education, than African American (AA) or Latina women.185  In another study of 
breast cancer screening, researchers identified women of Mexican origin as exhibiting 
diminishing returns compared not only to NHW women, but also to other Latinas.186  Therefore, 
disparities in screening adherence and subsequent breast and cervical cancer-related mortality 
appear to be highly sensitive to educational attainment, race/ethnicity, and country of origin. 
Patient navigation (PN) offers an intervention model originating from breast cancer 
disparities research that focuses on connecting un-/underserved communities to appropriate care 
within a fragmented health care system by addressing psychosocial barriers faced by women 
across the cancer continuum.13  Studies have demonstrated PN’s efficacy for increasing 
preventative screening uptake;14,15 however, PN has been defined broadly with questions about 
measuring its impact on health outcomes.16,17,113  Though studies have found that rural women 
screen for breast and cervical cancer at lower rates3 and suffer from later stage breast cancer 
diagnoses4 and higher breast and cervical cancer mortality rates 5 compared to urban residents, 
few studies have assessed interventions aiming to increase screening among these residents.   
Intervention 
Friend to Friend plus Patient Navigation (FTF+PN) was established in 2012 through a 
grant from the Cancer Prevention Research Institute of Texas (CPRIT) to expand an existing 
cancer education intervention operated by Texas A & M AgriLife Extension Service that sought 
to inform lower income, un-/underinsured women residing in approximately 70 rural and border 
counties across Texas aged 40+ who may be disabled, self-employed, and/or have limited 
English proficiency (LEP) about the need for timely breast and cervical cancer screening.  The 
grant provided funding for clinical services and the addition of four trained, lay patient 
navigators to compliment a team of five regional cancer specialists tasked with follow-up for 
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program participants and navigating their barriers to screening, such as transportation.  The 
intervention aimed to increase breast and cervical cancer screening rates according to American 
Cancer Society (ACS) guidelines for breast and cervical cancer that recommended annual 
mammograms for women aged 40-54 and biannual mammograms for those aged 55+ with 
average risk of breast cancer154 and Papanicolaou (Pap) tests every 3 years for women aged 21-
29 and every 5 years for women aged 30-64 with no additional screenings needed for women 
aged 65+ based on previously normal results.155   
Women attending the education intervention provided the main source of PN 
participants; however, other outreach activities conducted by the program staff identified women 
in need of PN who may not have been able to attend the initial FTF portion of the intervention.  
Fig. 6.1 illustrates the various data collection points and participant recruitment for the study.  
FTF participants completed a help request prompting PN staff to follow-up and complete an 
intake form when appropriate.  Also, women who had contacted program staff independently or 
women contacted by the staff due to a referral or request outside of the FTF event could also 
receive PN services.  Both groups received a follow-up survey approximately 6 weeks later to 
determine the results of the screenings; however, women not attending FTF lack the initial pre- 
and post-test data. 
Consequently, this analysis examines PN participants exclusively in order to evaluate the 
programmatic goal of reaching lower educated, women of color living in rural and border 
counties who are at risk of delayed screening. Statistical models include interaction effects of 
racial/ethnic/language categories with educational attainment in logistic regressions to determine 
the odds of screening outcomes to test if the diminishing returns hypothesis persists in this 
intervention. 
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Methods 
Data and measures 
This study analyzes program evaluation data collected from PN participants from March 
1, 2012 to November 5, 2016.  Participants had either sought PN services after attending a FTF 
event (FTF+PN) or were connected to PN services independently (PN only), and their follow-up 
responses were recorded in separate datasets.  The PN only database began with 2,884 unique 
participant follow-up surveys recorded during the study time frame.  Women who identified their 
race/ethnicity as American Indian or Native American (n=4), Asian, Asian-American, or Pacific 
Islander (n=20), multiple racial/ethnic categories (n=23), and other race/ethnicity or missing 
(n=15) were excluded due to small sample sizes.  Additionally, Latina participants who spoke a 
language other than English or Spanish at home (n=1) or did not indicate a language preference 
(n=41) were excluded to create exclusive categories for English Speaking Latina (ESL) and 
Spanish Speaking Latina (SSL) women.  Finally, women who had participated in the 
intervention more than once (n=267) were also excluded for a total of 2,513 PN only 
participants. 
The FTF+PN dataset for the same time frame began with 7,450 unique survey responses 
from intervention participants.  Women who chose not to receive PN (n=2,380) and who had not 
received follow-up interviews (n=1,451) were excluded from the analysis.  Small numbers of 
women identifying as American Indian or Native American (n=20), Asian, Asian-American, or 
Pacific Islander (n=29), multiple racial/ethnic/other categories (n=79) were once again excluded 
from the analysis.  Latina women who spoke a language other than English or Spanish at home 
(n=5) and those missing this response (n=57) were also excluded.  Next, women who repeated 
the intervention were removed (n=516) for a total of 2.913 FTF+PN participants.  Finally, the 
  
78 
 
datasets were combined, and participants omitting age (n=81) and education level (n=223) were 
excluded for a final analytic sample of 5,122 PN participants. 
Mammogram and Pap screening status determined from follow-up interviews serve as the 
outcome measures for the analysis.  AA, NHW, and Latina women stratified by primary 
language use at home comprise the principle demographic variable.  This variable categorizes 
women who exclusively identify as one of the racial/ethnic categories as well as differentiating 
Latinas who are English or Spanish speakers.  Language use is an indication of acculturation that 
has been used as the primary indicator of variation in acculturation studies and provides greater 
insights into the differences among Latina women in this sample.156  Age is determined from 
their year of birth, and education attainment is categorized by three levels:  did not complete high 
school, high school graduate, or some college or more.  The Institutional Review Board (IRB) of 
The University of Texas at Austin reviewed and approved (FWA # 00002030) the proposed 
study prior to analysis.   
Statistical Analysis 
Logistic regressions tested main and interaction effects of age, race/ethnicity, and 
education attainment on breast and cervical cancer screening outcomes for PN participants 
(N=5,122).  Separate models included women aged 40+ (N=3,721) for mammogram screening 
outcomes and aged 21-64 (N=4,879) for Pap screening outcomes as indicated by ACS guidelines 
at the time of the intervention.  First, demographic variables including age, race/ethnicity, and 
education attainment provided a baseline model.  Next, interaction terms multiplying 
race/ethnicity/language categories and education levels are added to the models.  Finally, 
significant interactions are further examined by stratifying education level according to each 
race/ethnicity/language category to examine the impact of higher educational attainment within 
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each group.  Analyses were conducted using SAS software, version 9.4 (SAS Institute, Cary, 
NC). 
Results 
  Women aged 40 to 64 comprised the largest share of the sample for each racial/ethnic 
group as noted in Table 5.9.  The sample distribution by education level reveals college educated 
AA, ESL, and NHW women represented the largest portion of PN participants while women 
with less than a high school education had the highest participation among SSL women.  As 
shown in Fig. 5.2, lower educated AA women also experienced the highest mammogram 
screening prevalence rate in contrast to college educated NHW women who experienced the 
highest prevalence rates for their respective racial/ethnic category.  In general, Pap screening 
prevalence rates were lower overall than mammogram prevalence rates, with AA and NHW 
women having the lowest rates overall and with high school educated SSL women achieving the 
highest screening prevalence rate at approximately 60%. 
 Table 5.10 reports the odds of mammogram screening among the sample of women aged 
40 and above and Pap screening for women aged 21-64.  The first model only found significantly 
lower odds of mammogram screening among older and ESL women, while SSL women 
experienced higher odds of screening compared to NHW women (OR=1.27, CI=1.06-1.53).  In 
the Pap screening model results, age was also significant with younger women experiencing 
higher odds of receiving a Pap test than older women.  In addition, ESL (OR=2.24, CI=1.78-
2.81) and SSL (OR=3.31, CI=2.82-3.90) women both had increased odds of screening for 
cervical cancer compared to NHW women.   
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 The second column for mammogram and Pap screening includes the interaction between 
race/ethnicity/language and education level.  For mammogram screening, the interaction model 
revealed that college educated AA women experienced lower odds of screening compared to 
lower educated AA women.  Similarly, high school educated ESL women (OR=0.41, CI=0.20-
0.86) and college educated SSL women (OR=0.47, CI=0.29-0.76) had lower odds of screening 
compared to their lower educated counterparts.  The Pap screening outcomes demonstrated 
significantly higher odds of screening for high school educated SSL women compared to SSL 
women with less than a high school education (OR=1.55, CI=1.02-2.35); however, none of the 
other interaction terms were significant. 
Logistic regression models stratified by race/ethnicity/language categories examined the 
findings from interaction models.  In Table 5.11, age was a significant variable among each 
group screening for breast cancer except for ESL women (although it was in the same direction), 
and there was no significant difference in screening outcomes for AA, ESL, and SSL women 
based on education level.  Meanwhile, the stratification revealed that both high school (OR=1.53, 
CI=1.05-2.23) and college educated NHW women (OR=1.58, CI=1.10-2.25) experienced more 
than 1.5 greater odds of screening for breast cancer compared to NHW women with less than a 
high school education.  In Table 5.12, Pap screening results found lower odds among older AA, 
SSL and NHW (ESL were in the same direction but not significant) women and higher odds of 
screening for high school educated SSL women (OR:1.31, CI:1.09-1.58) compared to their 
counterparts. 
Discussion 
 Studying the interaction between race/ethnicity and education attainment yielded 
valuable insights into breast and cervical cancer screening behavior among this sample of PN 
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participants in rural and border Texas; however, the findings did not support the diminishing 
returns hypothesis for either screening in this intervention.  The results demonstrated a 
progressive benefit based on education for NHW women screening for breast cancer, but all 
other groups failed to show the same pattern.  For Pap screening, education appeared not to 
factor into outcomes beyond one exception for high school educated SSL women.  Still, 
comparisons by race/ethnicity/language categories demonstrate the intervention’s focus on 
reaching Latina women, who have the highest incidence rates of cervical cancer in the U.S. and 
Texas.1  Furthermore, the findings reflect ACS guidelines highlighting the need for early 
screening among younger women compared to mammogram screening.  Overall, the Pap 
screening prevalence rates were much lower than the rates for mammogram screening.  Possible 
explanations for this variation may be related to perceived need for the exam, cost, and 
availability of services although these factors were not measured in the study. 
 Rather than interpreting these findings as not exhibiting diminishing returns, the results 
most likely reflect the intervention’s focus on lower educated women of color rather than the 
hypothesis’ origin in observational data of broader populations.184  Consequently, interpreting 
the results more broadly demonstrate that PN effectively mitigates lower educational attainment 
as a barrier to screening for most of the sample.  Thus, lower educated women in general did not 
screen differently than their higher educated counterparts, although higher findings for lower 
educated women would have more clearly substantiated this finding. 
 Qualitative findings from participant interviews also demonstrate how PN overcomes 
educational and other SES barriers that delay screening.  One example recounts a group of 
women who all had less than a fifth grade education and struggled with recording and 
understanding the details of their screening appointments.  The PN was able to identify and 
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respond to their scheduling difficulties and assist them with their screenings.  Multiple 
participants described how PNs helped them to access insurance coverage following a cancer 
diagnosis using various programs.  PNs connected these women to resources that they may have 
been previously unaware of while revealing an enduring relationship beyond screening that 
follows the continuing needs of participants.  Finally, many women also described the PN 
support related to the bureaucratic procedures that impeded their screening and treatment 
progress.  Many lower educated women found the paperwork to be overwhelming apart from 
connecting with providers spanning long distances from their homes.  Working with PN aided 
many to navigate these situations. 
 This study demonstrates that PN can disrupt established patterns of screening uptake 
among lower educated women, indicating some improvement in screening rates for lower 
educated women; however, PN faces distinct funding challenges as these services are not 
normally reimbursable expenses despite some cancer care organizations including PN as a 
standard part of clinical practice.20,175  Additionally, cancer care professionals who are charged 
with addressing psychosocial barriers to care, such as social workers, face workforce challenges 
to cover current gaps in service much less the expected growth in demand for these 
services.178,187  As a consequence, PN should be seen a system of care spanning health care and 
community professionals and lay individuals sharing a common goal of reducing health 
disparities by improving screening and treatment outcomes for individuals and groups.113  As 
professionals mandated to address the psychosocial barriers faced by patients, social work must 
play a key role in educating the current and future health care workforce to respond to the 
complex demands of treating both the physical and contextual factors across the cancer 
continuum.80,82 
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Limitations 
 The interpretation of the results of this study are limited in several ways.  First, the 
program intentionally sought un-/underserved women of color participants due to the risk for late 
stage diagnosis and higher cancer-related mortality; thus, it relies on a convenience sample.  
Program implementation varied by region to account for local differences in the population and 
available resources.  While this approach favored adaptation based on participants’ needs, the 
lack of consistent protocols limited the results.  Follow-up interviews had not been completed for 
all intervention participants at the time of the analysis leading to possible bias in the results (see 
Table 5.13).  Follow-up procedures varied from region to region with different roles for patient 
navigators and cancer prevention specialists leading to differences in follow-up screening rates.  
For example, the additional patient navigator in the South region increased their capacity to 
perform follow-up interviews at higher rates than the other regions.  Also, participants from year 
1 had a much longer timeframe to receive follow-up compared to participants in subsequent 
years.  Furthermore, variation in participant recruitment led to many women participating in the 
PN intervention but not the FTF portion.  While this encouraged screening among women who 
could not or would not attend the education intervention, participants did not complete pre- and 
posttest surveys during the events that would have contributed greater insights to the results. 
Finally, all responses were based on self-report with possible recall bias.  Also, both SES 
and acculturation were measured using a single item based on educational attainment and 
language use at home.  Additional items surveying income, wealth, and occupation would 
strengthen the validity of the SES findings, while more comprehensive measures of acculturation 
would refine the interpretation of screening behavior among Latina women. 
Conclusion 
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 Educational attainment plays an important role in cancer screening outcomes that affects 
health outcomes differently among racial/ethnic groups.  The results from this study further 
research into cancer screening behavior among women of varying education levels by 
racial/ethnic/language groups.  Mammogram screening appeared to be the most sensitive to 
educational attainment; however, it failed to support the diminishing returns hypothesis as 
greater educational attainment was not associated with screening prevalence for most groups.  
Still, the intervention reached key groups of women vulnerable to poorer outcomes including 
Latinas screening for cervical cancer.  Future studies with more comprehensive measures of 
socioeconomic status may provide greater insight into the screening behavior of disadvantaged 
women in rural and border Texas. 
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Table 5.9   
Sample distribution by demographic characteristics among patient navigation follow-up respondents (N=5,122), 
3/1/12-11/5/16. 
 African American 
(n=475) 
English Speaking Latina 
(n=449) 
Spanish Speaking Latina 
(n=2,754) 
Non-Hispanic White 
(n=1,444) 
Age (years)     
   21-39 26.8 34.8 28.3 20.8 
   40-64 69.8 60.5 68.5 74.5 
   65+ 3.4 4.7 3.2 4.7 
Education level     
  < high school 12.8 21.2 63.8 14.3 
  High school 37.7 35.9 23.8 34.3 
  Some college+ 49.5 43.0 12.5 51.4 
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Table 5.10 
Odds of mammogram screening among patient navigation follow-up respondents aged 40+ (N=3,721) and 
Papanicolaou (Pap) screening among respondents aged 21-64 (N=4,879), 3/1/12-11/5/16. 
 Mammogram Screening (N=3,721) Pap Screening (N=4,879) 
Age     
   21-39 - - ref. ref. 
   40-64 ref. ref. 0.72 (0.63-0.82)*** 0.72 (0.63-0.82)*** 
   65+ 0.41 (0.31-0.55)*** 0.40 (0.30-0.54)*** - - 
Race/ethnicity/language     
  African American 1.21 (0.93-1.57) 2.67 (1.27-5.61)** 1.19 (0.94-1.51) 1.46 (0.78-2.71) 
  English Speaking Latina 0.66 (0.51-0.86)** 1.16 (0.66-2.07) 2.24 (1.78-2.81)*** 2.28 (1.35-3.83)** 
  Spanish Speaking Latina 1.27 (1.06-1.53)* 1.87 (1.34-2.61)*** 3.31 (2.82-3.90)*** 2.82 (2.04-3.90)*** 
  Non-Hispanic White ref. ref. ref. ref. 
Education level     
  < high school ref. ref. ref. ref. 
  High school 1.02 (0.85-1.23) 1.51 (1.03-2.20)* 1.09 (0.94-1.27) 0.84 (0.58-1.22) 
  College+ 0.99 (0.81-1.21) 1.56 (1.09-2.23)* 0.95 (0.80-1.12) 0.87 (0.61-1.24) 
Race/ethnicity/language X 
education level 
    
  AA X <high school  ref.  ref. 
  AA X high school  0.43 (0.18-1.00)  0.76 (0.36-1.59) 
  AA X college+  0.37 (0.16-0.86)*  0.83 (0.41-1.67) 
  ESL X <high school  ref.  ref. 
  ESL X high school  0.41 (0.20-0.86)*  1.04 (0.54-1.98) 
  ESL X college+  0.58 (0.29-1.16)  0.93 (0.50-1.73) 
  SSL X <high school  ref.  ref. 
  SSL X high school  0.71 (0.45-1.11)  1.55 (1.02-2.35)* 
  SSL X college+  0.47 (0.29-0.76)*  1.00 (0.65-1.53) 
*P < .05, **P < .01, ***P < .001 
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Table 5.11 
Odds of mammogram screening among patient navigation follow-up respondents aged 40+ stratified by race/ethnicity, 3/1/12-11/5/16. 
 African American 
(n=342) 
English Speaking Latina 
(n=291) 
Spanish Speaking Latina 
(n=1,956) 
Non-Hispanic White 
(n=1,132) 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Age     
   40-64 ref. ref. ref. ref. 
   65+ 0.30 (0.11-0.83)* 0.80 (0.33-1.97) 0.44 (0.28-0.67)*** 0.31 (0.19-0.52)*** 
Education level     
  < high school ref. ref. ref. ref. 
  High school 0.64 (0.30-1.38) 0.66 (0.35-1.23) 1.06 (0.83-1.36) 1.53 (1.05-2.23)* 
  College+ 0.57 (0.27-1.22) 0.91 (0.50-1.65) 0.73 (0.54-1.00) 1.58 (1.10-2.25)* 
*P < .05, **P < .01, ***P < .001 
 
Table 5.12 
Odds of Pap screening among patient navigation follow-up respondents aged 21-64 stratified by race/ethnicity, 3/1/12-11/5/16. 
 African American 
(n=451) 
English Speaking Latina 
(n=425) 
Spanish Speaking Latina 
(n=2,640) 
Non-Hispanic White 
(n=1,363) 
 OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
Age     
   40-64 ref. ref. ref. ref. 
   65+ 0.60 (0.38-0.93)* 0.86 (0.58-1.28) 0.77 (0.65-0.92)** 0.58 (0.44-0.77)*** 
Education level     
  < high school ref. ref. ref. ref. 
  High school 0.63 (0.33-1.19) 0.89 (0.53-1.50) 1.31 (1.09-1.58)* 0.84 (0.57-1.22) 
  College+ 0.70 (0.38-1.30) 0.83 (0.50-1.38) 0.88 (0.69-1.12) 0.87 (0.61-1.24) 
*P < .05, **P < .01, ***P < .001 
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Table 5.13 
Chi square tests comparing the proportions of Friend to Friend plus Patient Navigation participants without follow-up interviews to participants with follow-up 
interviews (n=7,450), 3/1/12-11/5/16. 
Variable No follow-up (n, %)  Follow-up (n, %)  P 
Total 1,451  5,999   
Age      
   21-39 years 19.7  23.8  <.0001 
   40-64 years 47.9  61.1   
   65+ years 32.4  15.1   
Race/ethnicity/language (%)      
  African American 7.2  4.8  <.0001 
  English Speaking Latina 7.2  13.8   
  Spanish Speaking Latina 18.0  48.3   
  Non-Hispanic White 67.6  33.2   
Education level (%)      
   Did not complete high school 12.0  33.1  <.0001 
   High school graduate or GED 26.5  27.0   
   Some college or more 61.5  39.9   
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Fig. 5.1. Flowchart of Friend-to-Friend Plus Patient Navigation data collection. 
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Fig. 5.2. Mammogram and Papanicolaou (Pap) screening prevalence rates by 
race/ethnicity/language and education level among patient navigation follow-up respondents, 
3/1/12-11/5/16. 
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Conclusion 
 The analyses presented in this dissertation seek to contribute insights into breast and 
cervical cancer prevention behavior among rural and border residents of Texas by evaluating 
program participation and screening outcomes.  In doing so, this project fills an important gap in 
knowledge regarding the implementation of PN among rural populations.  FTF+PN represents a 
successful adaptation of PN to rural and border areas that incorporate traditional breast and 
cervical cancer screening services with the needs of these communities.  PN practice remained 
flexible to respond to the varying social contexts of the women in this study demonstrating the 
need to culturally and linguistically tailor interventions that speak to women’s needs while 
assessing their environmental context. 
 The findings from the literature review reveal that despite our understanding of the 
disadvantage that rural women face, very few studies draw from rural samples of women to 
understand how their experiences may vary from urban residents and report successful 
interventions specifically aimed at improving outcomes for this population.  In part, this focus 
may lie with the source of the studies often located in urban areas with easier access to study 
participants and service providers.  Still, the social context as evidenced by policies either 
supporting or detracting from prevention efforts is essential to contrast with studies that may 
have a more favorable policy environment.  The ACA expansion is a clear example where access 
to preventative screening with Medicaid access for low income individuals depends greatly on 
your place of residence.  Consequently, programs such as FTF+PN play a vital role in providing 
access to cancer care services by assisting with financial barriers to care.  Its broad sampling of 
women also highlights the variation in rural communities across the state. 
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Summary of Findings 
The formal analysis of the evaluation data began with Paper 1.  This analysis 
demonstrated the success of PN to increase both mammogram and Pap screening among 
intervention participants.  Lower educated women of color had higher odds of screening as the 
intervention sought to increase screening specifically among these women who experience 
disparate morbidity and mortality outcomes compared to higher educated, NHW women.  
Therefore, the intervention not only increases screening rates in general, it can be adapted to 
reach specific women and attempt to address population health disparities for un-/underserved 
women especially those concerned about financial barriers. 
 The next study further contextualized screening behavior in geographic context and its 
subsequent social implications.  The sample consisted of women with self-reported barriers to 
screening.  Overwhelmingly, women in the South region screened more than any other region for 
both exams.  For mammograms, county-level poverty corresponded to higher odds of screening 
demonstrating once again that the intervention responded to contextual and individual needs and 
adapted accordingly screening where the demand was highest for services.  Analyses for both 
screenings found lower odds for ESL women indicating that future interventions should consider 
these women distinctly when seeking to increase screening among these women.  Once again, 
screening rates were higher for women with barriers if they attended the intervention due to 
concerns for cost and participated in PN. 
 Finally, the third paper examined how education attainment affected screening outcomes 
within racial/ethnic categories.  Although NHW women saw a mammogram screening advantage 
based on education level, the findings for the other women were inconclusive.  The models 
found higher odds of mammogram screening for SSL women and higher odds for Pap screening 
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for ESL and SSL women; however, education appeared to play little to no role in screening 
outcomes among PN participants. 
Implications and Future Directions 
The Commission on Cancer (CoC) guidelines for high-quality cancer care require 
accredited institutions to provide psychosocial services including patient navigation, 
psychosocial distress screening, and survivorship care plans, yet striving to achieve this goal for 
all patients faces multiple implementation challenges.20  The current distribution of cancer care 
services favors urban areas as rural communities often lack institutions capable of meeting CoC 
standards leaving patients at a disadvantage of receiving comparable care.188  Meanwhile, a 
growing number of rural hospital closures have led to decreased health care services in general 
particularly among socioeconomically disadvantaged and racially/ethnically diverse 
communities.176  Moreover, cultural and financial barriers, inadequate public transport, and 
inaccessibility of broadband internet services compounded with scarce services and professionals 
negatively impact health care access for rural residents.189  Consequently, implementing 
psychosocial services by CoC standards requires consideration of environmental factors that act 
as barriers to practice and participation by residents in remote areas. 
Geographic evaluation of cancer-related health outcomes further substantiate the impact 
of the contextual factors on individual health and the relationship with provider resources.  For 
example, spatial analyses confirm communities of color and areas of low socioeconomic status 
(SES) in Texas experience higher late-stage diagnosis and poorer mortality rates compared to 
their counterparts for breast cancer.190  Similarly, area SES depravation in Texas has been 
associated with higher cancer-related mortality rates for non-Hispanic whites and African 
Americans and surprisingly lower for Hispanics, though areas with more uninsured Hispanic 
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residents and physician shortages experience delayed detection of breast, lung, colorectal, and 
female genital cancers.170  These examples further illustrate how environmental considerations in 
cancer care distinguish disadvantaged population groups with reduced access to cancer care 
services impacting health outcomes. 
CoC standards reflect oncology social work’s commitment to improving psychosocial 
outcomes for underserved patients by integrating whole-person care in their environment with 
cancer treatment.177  Still, maintaining standards of cancer care faces challenges due to growing 
shortages in cancer care professionals, rising treatment costs, and higher incidence rates of 
cancers among an expanding and aging population.178  Projections of social workers among these 
professionals confirm these issues.  Estimates indicate that Texas will have a shortage of over 
33,000 social workers by 2030, ranking it among the states with largest shortfalls of social 
workers in the country.187  At the same time, the Bureau of Labor Statistics191 expects health care 
social workers specifically to drive the largest share of growth in employment with 
approximately 191,000 positions expected nationally by 2024.  Although national analyses 
provide needed comparison among states, they fail to capture intra- or interstate spatial variation 
that may indicate areas of greater need due to professional shortages and area characteristics 
where professionals are found.  
 Insurance status for the adult population represents yet another barrier to care present in 
Texas, which has some of the highest rates of adults aged 18-64 uninsured in the nation.163  On 
average, over a fourth of the population of adults does not have insurance.  Thus, the widespread 
uninsured population prohibits access to health care leaving social workers with fewer resources 
to address psychosocial needs for disadvantaged individuals. 
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Technological innovations in psychosocial service delivery may offer the possibility to 
mitigate geographic isolation using telehealth and mHealth applications.88  Telehealth 
interventions vary greatly, but involve the dissemination of health-related services via 
telecommunication technology such as smartphones (mHealth) to monitor and care for 
individuals remotely.   Systematic reviews describe multiple service delivery approaches using 
mHealth applications to educate and support individuals across the cancer continuum; however, 
the authors note the need for further consolidation and refinement of this research to improve its 
evidence base.192,193  Despite the limitations of current research, technology-based interventions 
promise an innovative approach to reach isolated populations and the ability to tailor their 
interfaces for varying population groups based on language and culture.  Consequently, service 
providers may be able to leverage these advances to provide better quality care to un-
/underserved groups. 
Improving psychosocial service delivery including cancer screening services also relies 
on greater collaboration among health care professionals shaping health social work education.  
As health care responds to complex issues in population health, multidisciplinary education 
foments innovation in social work practice methods reflecting real-world settings and 
collaborative health care professional teams.73  Given social work’s practice orientation 
addressing a range of psychosocial factors contributing to health and wellbeing, social work is 
well positioned to lead and facilitate interprofessional education in health care.82  These lessons 
continue as leadership in oncology social work respond with continuing education initiatives for 
practitioners addressing multidisciplinary collaboration while maintaining social work values of 
person-centered, culturally-sensitive, and evidence-informed practice.80  Community engagement 
and practice are cornerstones of social work positioning the field to intervene in communities 
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drawing from established practice methods as well as new approaches to comprehensive health 
care delivery.  Multidisciplinary education establishes a paradigm to analyze service care 
delivery from multiple perspectives that may lead to future innovation to reach un-/underserved 
individuals. 
Future research should also examine individual SES factors beyond educational 
attainment with regards to cancer screening and subsequent care.  Wealth, for example, has been 
associated with both within and between group variation in health outcomes research.179,194  
These findings suggest future approaches to assessing SES indicators in cancer-related outcomes 
research that have been explored to a lesser degree compared to educational attainment.  While 
these factors may converge (e.g., low wage workers with lower educational attainment and low 
wealth), each element may impact outcomes differently among population subgroups and would 
contribute significant gap in extant literature on this topic. 
 A key element missing from this dissertation is a qualitative analysis.  Findings such as 
those outlined in the literature review could yield important insights not captured in the survey 
data.  The evaluation included qualitative data collection; however, the practical implications of 
appropriately sampling and collecting qualitative data were not feasible within the scope of this 
project.  Still, future inquiries should incorporate qualitative inquiry to strengthen the 
quantitative findings presented in the analyses and uncover any topics not addressed in the 
surveys. 
 To conclude, rural and border residents in Texas face multifaceted barriers to cancer 
screening and care that can be mitigated, in part, through evidence-informed interventions such 
as PN.  FTF+PN has supplied further evidence that programs adapted to their environmental 
context can successfully reach un-/underserved individuals in need of screening services with the 
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goal of reducing late stage detection of breast and cervical cancer among participants.  By 
adapting the program to reach women at the greatest risk for disparate outcomes, FTF+PN aims 
to foment greater health equity for disadvantaged groups of women and serve as a model for 
future health-related interventions bridging the gaps between the health care system and the 
community. 
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